Articulating suturing device with improved actuation and alignment mechanisms

Information

  • Patent Grant
  • 10426449
  • Patent Number
    10,426,449
  • Date Filed
    Thursday, February 16, 2017
    7 years ago
  • Date Issued
    Tuesday, October 1, 2019
    5 years ago
Abstract
A vessel closure device that includes improved activation and alignment mechanisms that result in greater control and ease of use for the user.
Description
BACKGROUND OF THE INVENTION

The present invention relates generally to apparatus and methods for the suturing of body lumens. More particularly, the present invention relates to techniques for percutaneous closure of arterial and venous puncture sites, which are usually accessed through a tissue tract.


A number of diagnostic and interventional vascular procedures are now performed translumenally. A catheter is introduced to the vascular system at a convenient access location and guided through the vascular system to a target location using established techniques. Such procedures require vascular access, which is usually established during the well-known Seldinger technique, as described, for example, in William Grossman's “Cardiac Catheterization and Angioplasty,” 3.sup.rd Ed., Lea and Febiger, Philadelphia, 1986, incorporated herein by reference. Vascular access is generally provided through an introducer sheath, which is positioned to extend from outside the patient body into the vascular lumen.


When vascular access is no longer required, the introducer sheath is removed and bleeding at the puncture site stopped. One common approach for providing hemostasis (the cessation of bleeding) is to apply external force near and upstream from the puncture site, typically by manual or “digital” compression. This approach suffers from a number of disadvantages. It is time consuming, frequently requiring one-half hour or more of compression before hemostasis is assured. Additionally, such compression techniques rely on clot formation, which can be delayed until anticoagulants used in vascular therapy procedures (such as for heart attacks, stent deployment, non-optical PTCA results, and the like) wear off. This can take two to four hours, thereby increasing the time required before completion of the compression technique. The compression procedure is further uncomfortable for the patient and frequently requires analgesics to be tolerable. Moreover, the application of excessive pressure can at times totally occlude the underlying blood vessel, resulting in ischemia and/or thrombosis. Following manual compression, the patient typically remains recumbent from four to as much as twelve hours or more under close observation to assure continued hemostasis. During this time renewed bleeding may occur, resulting in blood loss through the tract, hematoma and/or pseudo-aneurysm formation, as well as arteriovenous fistula formation. These complications may require blood transfusion and/or surgical intervention.


The incidence of complications from compression-induced hemostasis increases when the size of the introducer sheath grows larger, and/or when the patient is anticoagulated. It is clear that the compression technique for arterial closure can be risky, and is expensive and onerous to the patient. Although the risk of complications can be reduced by using highly trained individuals, dedicating such personnel to this task is both expensive and inefficient. Nonetheless, as the number and efficacy of translumenally performed diagnostic and interventional vascular procedures increases, the number of patients requiring effective hemostasis for a vascular puncture continues to increase.


To overcome the problems associated with manual compression, the use of bioabsorbable fasteners or sealing bodies to stop bleeding has previously been proposed. Generally, these approaches rely on the placement of a thrombogenic and bioabsorbable material, such as collagen, at the superficial arterial wall over the puncture site. While potentially effective, this approach suffers from a number of problems. It can be difficult to properly locate the interface of the overlying tissue and the adventitial surface of the blood vessel. Locating the fastener too far from that interface can result in failure to provide hemostasis, and subsequent hematoma and/or pseudo-aneurysm formation. Conversely, if the sealing body intrudes into the arterial lumen, intravascular clots and/or collagen pieces with thrombus attached can form and embolize downstream, causing vascular occlusion. Also, thrombus formation on the surface of a sealing body protruding into the lumen can cause a stenosis, which can obstruct normal blood flow. Other possible complications include infection, as well as adverse reaction to the collagen or other implant.


A more effective approach for vascular closure has been proposed in U.S. Pat. Nos. 5,417,699, 5,613,974; and PCT published Patent Application No. PCT/US96/10271 filed on Jun. 12, 1996, the full disclosures of which are incorporated herein by reference. A suture-applying device is introduced through the tissue tract with a distal end of the device extending through the vascular puncture. One or more needles in the device are then used to draw suture through the blood vessel wall on opposite sides of the puncture, and the suture is secured directly over the adventitial surface of the blood vessel wall to provide highly reliable closure.


While a significant improvement over the use of manual pressure, clamps, and collagen plugs, certain design criteria have been found to be important to successful suturing to achieve vascular closure. For example, it is highly beneficial to properly direct the needles through the blood vessel wall at a significant distance from the puncture so that the suture is well anchored in the tissue and can provide tight closure. It is also highly beneficial to insure that the needle deployment takes place when the device is properly positioned relative to the vessel wall. The ease of deployment and efficacy of the procedure can further be enhanced by reducing the cross-section of that portion of the device that is inserted into the tissue tract and/or the vessel itself, which may also allow closure of the vessel in a relatively short amount of time without imposing excessive injury to the tissue tract or vessel.


Another issue common among many of the prior art devices is the need for the user to reposition her or his hands one or more times during placement and operation of the closure device. Therefore, an actuation mechanism with improved ergonomic design that provides greater control and ease of use would also be desirable.


For the above reasons, it would be desirable to provide improved devices, systems, and methods for suturing vascular punctures. Such devices would have the capability of delivering a pre-tied knot to an incision site. It would be particularly beneficial if these improved devices provided some or all of the benefits while overcoming one or more of the disadvantages discussed above.


DESCRIPTION OF THE BACKGROUND ART

U.S. Pat. Nos. 5,700,273, 5,836,956, and 5,846,253 describe a wound closure apparatus and method in which needles are threaded with suture inside a blood vessel. U.S. Pat. No. 5,496,332 describes a wound closure apparatus and method for its use, while U.S. Pat. No. 5,364,408 describes an endoscopic suture system.


U.S. Pat. No. 5,374,275 describes a surgical suturing device and method of use, while U.S. Pat. No. 5,417,699 describes a device and method for the percutaneous suturing of a vascular puncture site. An instrument for closing trocar puncture wounds is described in U.S. Pat. No. 5,470,338, and a related device is described in U.S. Pat. No. 5,527,321, U.S. Pat. No. 5,507,757 also describes a method of closing puncture wounds.


SUMMARY OF THE INVENTION

The present invention provides improved devices, systems, and methods for suturing of body lumens. The device often allows the suturing of vascular puncture sites located at the distal end of a percutaneous tissue tract with greater ease, in less time, and with less patient trauma than known systems. These improvements are generally provided through the use of shafts having smaller cross-sections than prior suturing systems. In the exemplary embodiment, an elongate articulated foot near a distal end of a shaft is inserted through the penetration and actuated so that the foot extends along the lumenal axis. The foot carries suture attachment cuffs, and can be drawn proximally up against the endothelial surface of the blood vessel. Needles are advanced from the shaft, through the vessel wall beyond the penetration, and into engagement with the needle cuffs. The cross-section of the shaft within the tissue tract can be minimized by laterally deflecting the needles before they leave the shaft, while tapered depressions within the foot can help guide the advancing needles into engagement with the cuffs. The cuffs positively engage and capture or trap the needles so that the cuffs can be withdrawn proximally along the needle paths through the tissue tract to form a loop of suture across the puncture without having to thread the needles directly with the suture inside the blood vessel. The suture loop may be drawn distally from the shaft, proximally from within the blood vessel, or laterally down one of the needle paths, across the puncture, and out the opposing path. Regardless, the articulating foot may be realigned with the shaft and withdrawn proximally through the tissue tract in a small profile configuration. The use of an articulatable foot in combination with lateral deflection of the needles can avoid dilation of the tissue tract, as was often necessary using known puncture closure systems.


In a first aspect, the invention provides a method for suturing a puncture through a vessel wall of a blood vessel. The puncture is disposed within a tissue tract of a patient body, and the method comprises attaching a flexible filament to a first fitting. The first fitting is inserted through the tissue tract and positioned adjacent the vessel wall, and a needle path is formed by advancing a first needle through the vessel wall. The needle is coupled with the first fitting, and the first needle, the first fitting, and at least a portion of the filament are withdrawn through the vessel wall along the needle path.


First and second fittings will often be coupled to the flexible filament, and will generally be positioned so that the puncture is disposed therebetween. The flexible filament will often comprise a suture extending between the first and second fittings, with each fitting being drawn proximally by an associated needle to form the suture loop. Alternatively, at least one of the needles may include a detachable tip and may advance a suture distally along the needle path as the needle penetrates through the vessel wall. The flexible filament can again couple the first and second fittings, here allowing both fittings to be withdrawn along a single needle path so that the suture advances down along the first needle path, laterally across the puncture, and then out the other needle path.


Positioning of the fittings is generally effected by articulating an elongate foot within the blood vessel so that the foot extends along the vessel axis. A confirmation lumen may extend along a shaft supporting the foot to ensure that the foot is positioned within the vessel prior to articulation. Once the foot is properly articulated, it can be drawn proximally to firmly engage the endothelial layer of the vessel. The foot will preferably include tapering depressions which direct the advancing needle toward the fitting, and the suture or other flexible filament adjacent the fittings will often be releasably restrained within a narrow slot extending from the depression. The suture or other flexible filament and its associated slot will preferably be arranged to avoid entanglement of the advancing needle in the suture, and to ensure that the fitting and suture can be withdrawn proximally as the needle is retracted. An atraumatic, flexible monorail guidebody may extend from the shaft and/or the articulatable foot to facilitate alignment of the foot with the vessel, and also to help provide hemostasis while the knot is tied. A wide variety of foot articulation mechanisms may be provided, with deployment preferably being effected when the foot is disposed entirely within the vessel and using an actuator and foot motion that avoid dilation of the puncture.


In another aspect, the invention provides a method for suturing an opening in a tissue. The method comprises inserting a distal end of a probe through the opening, the probe defining a probe axis. An elongated foot of the probe is articulated so that first and second ends of the foot extend laterally with the opening aligned therebetween. A first needle path is formed from the probe, through the tissue, and to the first end of the foot. A second needle path is formed from the probe, through the tissue, and to the second end of the foot. Suture is advanced along the first and second needle paths to position a suture loop across the opening.


In another aspect, the invention provides a method for suturing a blood vessel. The vessel has a vessel wall, and the method comprises advancing a shaft toward the vessel wall. The shaft has an axis and a plurality of needle guides. A foot is deployed adjacent the vessel wall so that the foot extends laterally from the shaft. A plurality of needles are advanced from the needle guides of the shaft to the foot to form needle paths through the vessel wall. The needle guides deflect the needles laterally so that a needle path width between the needles is greater than a cross-sectional dimension of the shaft. Suture is advanced along the needle paths to position at least one suture loop across the puncture.


In yet another method of the present invention, a blood vessel is sutured through a tissue tract of a patient body. The vessel has a vessel wall, and the method comprises inserting a distal end of a probe through the puncture and into the blood vessel. A first end of the suture is advanced from the probe within the tissue tract, through the vessel wall, and into the vessel. The first end of the suture is withdrawn from the vessel through the vessel wall, and through a bight of the suture to form a loop of suture across the puncture. The first end of the suture and a second end of the suture adjacent the bight are tensioned to detach the bight from the probe and form a knot affixing the loop of suture across the puncture. Advantageously, the bight of suture may be pre-tied before the probe is inserted into the tissue tract, the bight optionally being releasably attached to the probe.


In a device aspect, the invention provides a system for suturing a blood vessel. The vessel has a vessel wall, and the system comprises a needle having a proximal end and a distal end suitable for forming a needle path through the vessel wall. The needle has a recessed engagement surface adjacent the distal end. The system further comprises a flexible filament and a fitting attached to the filament. The fitting has an opening and a tab extending into the opening, the tab securingly engaging the engagement surface when the needle advances through the vessel wall and into the opening, so that the fitting and at least a portion of the filament can be withdrawn proximally along the needle path by the needle.


In a further device aspect, the invention provides a system for suturing a puncture of a blood vessel within a tissue tract. The vessel has a vessel wall and defines an axis, and the system comprises a shaft having a proximal handle and a distal end suitable for insertion along the tissue tract and into the vessel through the puncture. A foot is mounted near the distal end of the shaft. The foot has plurality of needle receptacles extendable laterally from the shaft. A flexible filament extends between the receptacles of the foot. A plurality of needles are advanceable distally and laterally from the shaft, through the vessel wall outside the puncture, and to the receptacles of the foot.


In yet another device aspect, the invention provides a system for suturing a puncture of a blood vessel within a tissue tract. The vessel has a vessel wall, and the system comprises a shaft having a proximal handle and a distal end suitable for insertion along the tissue tract and into the vessel through the puncture. A foot is mounted near the distal end of the shaft. The foot has a first needle receptacle and is articulatable from a small profile configuration to a large profile configuration by actuation of the handle. A first fitting is removably mounted adjacent the first needle receptacle. A filament is coupled to the first fitting. A first needle is advanceable from the shaft to the first needle receptacle on the articulated foot. The first fitting securely engages the first needle so that the secured first fitting and at least a portion of the filament can be drawn through the vessel wall by the first needle.


In a still further device aspect, the invention provides a probe for suturing an opening in a tissue. The probe comprises a shaft having a proximal end and a distal end and defining an axis therebetween. The shaft has a size and configuration suitable for insertion through the opening in the tissue. An elongate foot is movably mounted to the shaft. An actuator extends along the shaft distally to the foot. Movement of the actuator slides the foot axially and pivots the foot from a low profile configuration to a deployed configuration extending laterally from the shaft. A suture is supported by the foot, and a needle is advanceable from the shaft, through the tissue, and to the deployed foot.


In another aspect, the invention provides a suturing device having a first penetrator and a second penetrator for suturing an incision. The first penetrator is configured to form a first penetration about a periphery of the incision. The first penetrator also carries a pre-tied knot disposed about a periphery of the first penetrator for delivery to the incision. The second penetrator is configured to form a second penetration about the periphery of the incision. The second penetrator also includes suture disposed thereon that is drawn by the first penetrator through the first penetration and through the pre-tied knot during retraction of the first and second penetrators from around the periphery of the incision. The first penetrator draws the suture through the first penetration via a connection between the first penetrator and the suture. Moreover, as the first penetrator draws the suture, the suture delivers the pre-tied knot to the incision for closure of the incision.


In another aspect, the invention provides a suturing device for suturing an incision formed in an artery. The suturing device includes a first penetrator, a second penetrator and a receiver. The first penetrator, which forms a first penetration about a periphery of the incision, includes a pre-tied knot disposed about the first penetrator. The second penetrator, which forms a second penetration about the periphery of the incision, has suture disposed thereon, which retracts through the first penetration. The suture retracts through the first penetration into the pre-tied knot during retraction of both the first penetrator and the second penetrator from around the periphery of the incision. In addition, during retraction, the suture delivers the pre-tied knot to the incision for suturing of the incision. The suturing device also includes a receiver for receiving both the first penetrator and the second penetrator upon penetration formation. The receiver connects the suture to both the first penetrator and the second penetrator and allows retraction of the suture through the first penetration as the first penetrator and the second penetrator retract.


In another aspect, the invention provides a suturing device for suturing an opening of an artery of a patient during a surgical procedure. The suturing device includes a first penetrator, a second penetrator and a foot. The first penetrator is disposed about a periphery of the suturing device and the second penetrator is located opposite the first penetrator on the suturing device. The first penetrator includes a pre-tied knot configured to receive suture releasably engaged with the second penetrator during suturing of the opening of the artery. The foot, which is movably coupled to the suturing device distal to the first penetrator and the second penetrator, includes a first cuff and a second cuff. The first cuff and the second cuff, which couple to one another via a link, receive the first penetrator and a detachable end of the second penetrator respectively. The first and second penetrators penetrate the artery at a proximal end of the suturing device and couple with the first cuff and the second cuff upon penetration of the artery. The first and second penetrators couple with the first cuff and second cuff such that during retraction of the first penetrator and the second penetrator from the artery, the suture delivers the pre-tied knot to the incision for closure of the incision.


In various aspects and embodiments of the invention described herein, a pre-tied knot of suture is also included. The pre-tied knot may initially be positioned wrapped around an exterior surface of the device. Specifically, a length of suture having opposite ends and a bight of suture therebetween is provided with the bight being disposed around an exterior surface of the device.


In other aspects and embodiments described herein, a suture cutting blade is positioned on the device. The suture cutting blade provides a convenient cutting edge across which the suture can be drawn to sever the suture from the needle.


Another aspect and embodiment described herein is to provide an improved activation mechanism for the suturing device, which provides an improved ergonomic design that results in greater control and ease of use for the user.


Yet another aspect is to provide alignment guides to assist in the placement and rotational orientation of a suture relative to the vessel opening, to facilitate the use of multiple sutures with different angular orientations, as necessary, to close vessel punctures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective of a percutaneous blood vessel closure device according to the principles of the present invention.



FIGS. 2A-C illustrate actuation of a foot and advancement of needles from a shaft to the articulated foot in a probe similar to the probe of FIG. 1.



FIG. 3A is a detailed view showing the foot of the vessel closure device of FIG. 1 in a parked position prior to deployment.



FIG. 3B is a detailed view showing the foot of the vessel closure device of FIG. 1 in a deployed position.



FIGS. 4 and 4A are perspective views illustrating a suture attachment cuff and an associated barbed needle for use in the vessel closure device of FIG. 1.



FIG. 5 is a cross-sectional view showing the barbed needles securingly engaging the suture cuffs of the deployed foot.



FIGS. 6A-C illustrate one embodiment of a deployable foot, in which the foot slides and pivots when drawn proximally by a tension member.



FIG. 7 illustrates the suture cuff positioned within a needle receptacle, and also shows how the suture is releasably secured within a slot extending radially from the needle receptacle.



FIGS. 8A-G illustrate a method for use of a suture system to effect hemostasis of a blood vessel puncture through a tissue tract.



FIG. 9 is a perspective view of a suturing device including a suture cutting blade positioned on the device.



FIG. 10 is a perspective view of another embodiment of a vessel closure device.



FIGS. 10A and 10B are top and side views, respectively, of another embodiment of a vessel closure device.



FIGS. 11A-D illustrate various steps in the operation of the vessel closure device.



FIG. 12 is a plan view of the vessel closure device with the top of the housing removed, showing the internal components located within the proximal housing of the device.



FIG. 13 is a detail view of the distal end of the housing, illustrating multiple alignment markings.



FIGS. 14A-C are schematic representations of different angular orientations that can be achieved through the use of the multiple alignment markings of the device.





DETAILED DESCRIPTION

Several embodiments of suturing device that delivers a pre-tied knot to a puncture or incision in a wall of tissue is disclosed. Various aspects of such a device include a length of suture having a bight between first and second ends of the suture. The bight includes one or more loops of suture that form a pre-tied knot when one or more ends of the suture are advanced through the bight. The bight of suture may be prearranged in any of several configurations on the device.


Referring now to FIG. 1, a vessel closure device 10 generally has a shaft 12 having a proximal end 14 and a distal end 16. A proximal housing 18 supports a needle actuation handle 20. A flexible, atraumatic monorail guidebody 22 extends distally of distal end 16 of shaft 12.


As can be seen with reference to FIGS. 2A through C, a foot 24 is articulatably mounted near the distal end of shaft 12. Foot 24 moves between a low profile configuration, in which the foot is substantially aligned along an axis of shaft 12 (as illustrated in FIG. 1), to a deployed position, in which the foot extends laterally from the shaft, upon actuation of a foot actuation handle 26 disposed on proximal housing 18.



FIGS. 2A through C illustrate the structure and actuation of foot 24 of an embodiment of probe 10, and also show how needles 38 can be advanced distally from shaft 12 to the foot by depressing needle actuation handle 20 (see FIG. 2C).


Actuation of foot 24 is illustrated more clearly in FIGS. 3A and B. In the parked position illustrated in FIG. 3A, foot 24 extends substantially along axis 28 of shaft 12. Note that the axis of the shaft need not be straight, as the shaft may curve somewhat, particularly adjacent the foot. In the exemplary embodiment, foot 24 is substantially disposed within a foot receptacle 30 of shaft 12 to minimize the cross-section of the device adjacent the foot prior to deployment. Advantageously, prior to deployment of the foot, device 10 can have a cross-section adjacent foot 24 of about 7 Fr or less, ideally having a cross-section of about 6 Fr or less for the entire device distally of the proximal end 14 of shaft 12.


Actuation of foot handle 26 slides a foot actuation wire 32 proximally, pulling foot 24 from a parked position to the deployed position illustrated in FIG. 3B. Once deployed, a first end 24a and a second end 24b of foot 24 extend laterally from the shaft. Suture 34 here comprises a continuous filament with ends disposed in needle receptacles adjacent each end of the foot. An intermediate portion of suture 34 may extend proximally along a suture lumen of shaft 12 to and/or beyond proximal housing 18. Alternatively, the length of suture between the ends may extend distally within flexible guidebody 22, preferably in a dedicated lumen (separate from the monorail guidewire lumen). In still further alternatives described below, a short length of suture or some other flexible filament may extend substantially directly between the needle receptacles.


Shaft 12 also includes a foot position verification lumen that extends distally from a position verification port 36 to a position indicator at housing 18. When the foot is properly positioned within the blood vessel, blood pressure will cause blood to flow proximally through the indicator lumen to the indicator. The indicator may optionally comprise a blood exit port, a clear receptacle in which blood is visible, or the like. In the exemplary embodiment, the indicator of handle 18 comprises a length of clear tubing extending from housing 18 (not shown) in which the blood is clearly visible. It should be understood that a wide variety of alternative position verifications sensors might be used, including electrical pressure sensors, electrolytic fluid detectors, or the like.


The structures used in positioning a loop of suture across the puncture can be understood with reference to FIGS. 4, 4A, and 5. In general terms, needles 38 extend from shaft 12 into secured engagement with fittings 40 attached to sutures 34. More specifically, needles 38 include a barbed end 42 defining a recessed engagement surface 44. Fittings 40 are roughly cylindrical structures having an axial channel 46 which receives barbed end 44 of needle 38 therein. A first slot is cut in fitting 44 to define at least one tab 48. Tabs 48 can be resiliently biased inward into channel 46. As needle 38 advances into fitting 40, barbed end 42 resiliently displaces tab 48 clear of channel 46 to allow the barbed end to pass axially into the fitting. Once barbed end 42 is disposed axially beyond tab 48, the tab resiliently flexes back into the channel, capturing needle 38 by engagement between the tab and recessed surface 44. As each tab can hold the fitting in place on the needle, the use of more than one tab increases the reliability of the system. Ideally, three tabs are provided, as illustrated in FIG. 4A.


To facilitate attachment of fitting 40 to suture 34, a second slot cut in the tubular fitting structure defines a suture attachment collar 50. Optionally, collar 50 may be crimped about suture 34 to mechanically affix the suture to fitting 40. In addition and/or instead of mechanical crimping, suture 34 may be bonded to fitting 40 using an adhesive, heat, fasteners, knots, or the like.


Fitting 40 is quite small in size, and is generally configured to facilitate withdrawing the fitting (and the attached suture) along with needle 38 axially through the vessel wall along the needle path. Needle 38 will generally have a cross-sectional width of between about 0.010 inches and 0.020 inches. Barb 42 will extend laterally to define an engagement surface 44 having a protruding length of between about 0.002 inches and 0.005 inches. Fitting 40 will preferably have a cross-sectional size roughly corresponding to or only slightly larger than needle 38. Fitting 40 will typically have an outer lateral width of between about 0.014 inches and 0.025 inches, and an axial length of between about 0.035 inches and 0.050 inches. Channel 46 will be sized to receive at least a portion of needle 38, and will generally have a width of between about 0.010 inches and 0.020 inches. Suture 34 will preferably extend axially opposite the open end of channel 46 to minimize drag when the suture is drawn proximally along the needle path. In the exemplary embodiment, needle 38 has a diameter of about 0.020 inches, while the fitting comprises a tube having an outer diameter of about 0.020 inches, an inner diameter of about 0.016 inches, and an overall length of about 0.047 inches. The fitting will typically comprise a resilient material, preferably comprising a metal, and in the exemplary embodiment, comprising stainless steel.


Needles 38 typically have a length of between about 5.0 inches and 6.0 inches, and will preferably be sufficiently stiff to be advanced in compression through the vessel wall (and adjacent tissues) for up to 0.5 inches when supported in cantilever. Nonetheless, the needles will ideally be flexible enough to be laterally deflected within shaft 12, as can be understood with reference to FIG. 5. Needles 38 generally comprise a high strength metal, ideally comprising stainless steel. Fittings 40 will also preferably comprise a flexible material to allow tab 48 to flex out of the way of barbed end 42, and to resiliently rebound and engage recessed surface 44. In the exemplary embodiment, barbed end 42 has a diameter of about 0.015 inches, with the diameter of the needle decreasing to about 0.008 inches proximally of the barb to define the recessed engagement surface.


As was generally described above, foot 24 includes needle receptacles 52 adjacent the ends of the foot. A fitting 40 (with an associated end of suture 34) is disposed within each needle receptacle, and a surface of the receptacle tapers proximally and outwardly so as to guide the advancing needles 38 into engagement with fittings 40 when foot 24 is in the deployed position. As fittings 40 (and associated portions of suture 34) are releasably supported in the foot, needles 38 can be withdrawn proximally so as to draw the fittings and suture ends from the foot proximally into (and optionally through) shaft 12. The needle receptacles of the exemplary embodiment taper outward at an angle between 20 and 35 degrees from the centerline of fitting 40, and the fitting is held in a recess having a diameter of about 0.0230 inches and a length of about 0.042 inches. A lateral opening or window through the side of foot to the fitting recess may be provided to facilitate needle and/or cuff positioning during assembly of the probe, and a protruding collar near the proximal end of the fitting recess may help keep the fitting in position.


A wide variety of foot actuation mechanisms might be used within the scope of the present invention.



FIG. 5 also illustrates the lateral deflection of needles 38 by needle guides 54 of shaft 12. This lateral deflection of the needles allows the use of a small diameter shaft, while still encompassing sufficient tissue within the suture loop on opposite sides of the puncture to effect hemostasis when the suture looped is tightened and secured. In the exemplary embodiment, shaft 12 comprises an outer casing of a biocompatible material such as stainless steel, carbon fiber, nylon, another suitable polymer, or the like. Needle guides 54 may be defined at least in part as lumens formed within the casing of a polymeric material such as nylon or the like. In some embodiments, shaft 12 may comprise a carbon fiber filled nylon, or carbon fiber filled with an alternative material.


One example of a suitable structure and articulation motion for foot 24 is illustrated in FIGS. 6A and B. Foot actuation wire 32 (see FIG. 3A) rides in a lumen of shaft 12, and draws foot 24 from a parked position (shown in FIG. 6A) to a deployed position (shown in FIG. 6B) through a combination of sliding and pivoting of the foot. The foot remains supported throughout its range of motion by arms disposed laterally on either side of the foot, the arms defining (at least in part) foot receptacle 30. Once foot 24 is deployed, needle receptacles 52 and/or the fittings disposed therein will preferably define a lateral suturing width 56 in a range from about 0.260 inches to about 0.300 inches. Foot 24 may be machined or cast from a polymer or metal, but will preferably comprise a polymer such as carbon fiber or glass-filled nylon or suitable reinforcement material. In some cases, foot 24 may be molded as two separate halves which can subsequently be affixed together. Needles 38 advance from the fixed needle guides 54, and are laterally directed into fittings 40 by receptacles 52, as illustrated in FIG. 6C. In general, a shape memory alloy such as Nitinol® in its superelastic regime provides a particularly advantageous actuator wire for manipulating foot 24. A wide variety of foot designs and foot actuation mechanisms can be used within the scope of the invention.


Referring now to FIG. 7, fittings 40 and suture 34 will be withdrawn proximally by the needles from needle receptacles 52. To releasably support fittings 40 and suture 34 and avoid entanglement of the suture in the needles, suture 34 is fittingly received within a slot 58 which extends laterally from needle receptacles 52. As the needles pull the fitting axially from needle receptacles 52, suture 34 is pulled from slot 58 and free from foot 24. Bending of the suture proximally within the suture slot can also locally increase the suture width, so that the interaction between the bent suture and the slot can help hold the fitting in the recess.


The operation and use of probe 10 can be further understood with reference to FIGS. 8A-G. After accessing a blood vessel V (often using the Seldinger technique), a guidewire GW is left extending into skin S and down through tissue T along tissue tract TT. Guidewire GW enters vessel V through a puncture P in vessel wall W, and extends along the vessel throughout many endovascular procedures. As illustrated in FIG. 8A, distal guidebody 22 is advanced over the guidewire GW in a monorail fashion, so that the guidewire helps to direct the probe along the tissue tract TT and into the vessel through puncture P. FIG. 8B shows that when sensor 36 is disposed within the vessel, blood can flow from the sensor port and through a lumen in shaft 12 to the proximal handle to notify the operator that foot 24 has been advanced far enough for deployment.


Deployment of the foot is effected by actuation of the foot deployment handle 26, as described and illustrated above with reference to FIGS. 2, 2B and 3B. As described above, guidebody 22 helps to align the probe with the axis of vessel V. Guidebody 22 may be set at an angle and/or offset relative to shaft 12 as appropriate to aid in alignment with a particular vessel access technique. As shown in FIG. 8C, the deployed foot 24 extends laterally from the shaft, so that foot 24 adjacent receptacles 52 can be drawn up against vessel wall W by gently pulling shaft 12. Hence, the foot helps to accurately position the needle guides 54 at a distance from the vessel wall.


Referring now to FIG. 8D, once foot 24 is properly positioned against the inner surface of the vessel wall, flexible needles 38 can be advanced through the vessel wall by depressing needle actuator handle 20, thereby advancing needle actuator handle 20 and flexible needles 38 in a distal direction. As they are advanced distally, flexible needles 38 are deflected laterally by needle guides 54 toward receptacles 52 of the deployed foot. As a result, the needles advance in cantilever both distally and laterally when needle actuation handle 20 is pressed (see FIG. 2C), and the tapering surfaces of receptacles 52 help to push the needles back into alignment with the fittings so as to overcome any unintended deflection of the needles by tissue T or vessel wall W. This ensures that needles 38 securingly engage fittings 40 within receptacles 52 (see FIGS. 5, 6C and 7), thereby coupling the ends of suture 34 to the needles. While suture 34 is here illustrated running along the side of shaft 12 outside foot receptacle 30 to a lumen within guidebody 22, it should be understood that the suture loop might instead extend proximally in a lumen of shaft 12, might be routed through the foot and/or foot receptacle, and/or might be stored in a spool adjacent foot 24. Regardless, suture 34 should able to pull free of the probe between its ends to form a continuous loop across puncture P.


Referring now to FIGS. 8E and F, once the needles 38 have been fully advanced into, and engage, fittings 40, the needles 38, with fittings 40 and suture 34 now attached to the ends of needles 38, can then be withdrawn proximally by pulling on needle actuation handle 20 (FIG. 2C) in a proximal direction. Fittings 40 and the ends of suture 34 are drawn proximally through the vessel wall W along the needle paths formed by needles 38. Optionally, the needles may be withdrawn proximally out of the tissue tract and clear of shaft 12, or they may remain coupled to the shaft within needle guides 54.


Once the needles 38 are withdrawn into the needle guides, the foot actuator 26 is moved to store foot 24 along shaft 12, and the shaft can then be pulled proximally from the tissue tract. Guidebody 22, which may comprise a soft, compliant polymer, may temporarily extend at least partially into tissue tract TT and through puncture P to help reduce the loss of blood until the loop is secured.


Now referring to FIG. 8G, once shaft 12 has been withdrawn sufficiently to expose needle guides 54, the ends of the suture loop can be grasped by the operator. Tying of a knot in suture 34 can then proceed in a conventional manner. The use of a clinch knot may facilitate gradual tightening of the knot while removing guidebody 22, although a wide variety of knot and knot advancing techniques might be used.


As shown in FIG. 9, the suturing device 10 may also include a blade 60 positioned on the device to provide a convenient cutting edge to sever the suture to detach the suture from the needle or needles. FIG. 9 shows a suturing device 10 of the type having an articulated foot described herein. The suturing device 10 is particularly useful for suturing an opening in a femoral artery of a patient after the completion of a percutaneous transluminal catherization procedure, or the like. Suturing device 10 is an example of the type of device that may include a blade 60 positioned on the device. For convenience of description, only this suturing device embodiment will be described with respect to the suture cutting blade feature. It is to be understood, however, that any suturing device employing a needle and suture to close an opening in a tissue wall may incorporate the suture cutting blade feature described more fully below.


The suturing device 10 shown in FIG. 9 includes a housing 18. One or more needles 38 are operatively associated with the device. The needles 38 are movable with respect to the housing 18. The needles 38 are shown in FIG. 9 withdrawn from the housing 18. In this exemplary embodiment, only one of the two needles 38 are shown attached to a length of suture 34. In other embodiments, both needles may be attached to the suture 34. Alternatively, the device may only include one needle.


A suture cutting blade 60 is positioned on the device 10 such that when the needle 38 and attached suture 34 are withdrawn from the device, the suture 34 can be drawn across the blade 60 to sever the suture. FIG. 9 shows the position of the needle and suture with respect to the housing 18 and the blade 60 just prior to the suture being cut to detach the needle 38 from the length of suture. As can be seen in FIG. 14, a portion of the suture may remain attached to the needle 38 due to the suture being cut at a short distance from the end of the needle. The length of suture that is used to close the opening in the tissue will be detached from the needle or needles. Once the needle 38 is cut away from the length of suture that has been withdrawn from the proximal end 22 of the housing 18, the device 10 can be removed from the patient's anatomy without interference from the needle actuation handle 20.


Additional details regarding such articulating suturing devices and methods are provided in: U.S. patent application Ser. No. 15/090,150, filed Apr. 4, 2016, and entitled “Articulating Suturing Device and Method;” U.S. patent application Ser. No. 14/195,308, filed Mar. 3, 2014, and entitled “Articulating Suturing Device and Method;” U.S. patent application Ser. No. 12/334,077, filed Dec. 12, 2008, and entitled “Articulating Suturing Device and Method,” now U.S. Pat. No. 8,663,248; U.S. patent application Ser. No. 10/660,288, filed Sep. 11, 2003, and entitled “Articulating Suturing Device and Method,” now U.S. Pat. No. 8,137,364; U.S. patent application Ser. No. 10/652,182, filed Aug. 29, 2003, and entitled “Articulating Suturing Device and Method,” now U.S. Pat. No. 7,235,087; U.S. patent application Ser. No. 10/152,272, filed May 20, 2002, and entitled “Articulating Suturing Device and Method,” now U.S. Pat. No. 6,964,668; U.S. patent application Ser. No. 09/651,344, filed Aug. 29, 2000, and entitled “Articulating Suturing Device and Method,” now U.S. Pat. No. 7,001,400; and U.S. patent application Ser. No. 09/262,402, filed on Mar. 4, 1999, and entitled “Articulating Suturing Device and Method,” now U.S. Pat. No. 6,136,010, each of which is hereby incorporated by reference in its entirety.


One issue associated with the embodiments described above is that, during use of the device 10, a user (surgeon) must reposition her or his hands several times during use. For example, it is common for the surgeon to hold the proximal end of housing 18 with one hand and to hold and stabilize the distal end of housing 18 with the other hand while advancing the device over the guidewire and inserting the device through the tissue tract. Once device 10 is inserted far enough into the vessel that blood flows into the device 10 and out of the blood sensor port (thereby indicating that device 10 is properly positioned within the vessel so as to allow foot 24 to be deployed), then the surgeon must release the distal end of housing 18, reposition her or his hand to deploy foot 24 by manipulating foot actuation handle 26. Then, it is common for the surgeon to reposition her or his hand to again stabilize the distal end of housing 18 (i) as the device is drawn proximally to position foot 24 against the inner surface of the vessel wall, (ii) as needles 38 are advanced distally to engage fittings 40, and (iii) as needles 38, fittings 40 and suture 34 are withdrawn proximally from the tissue tract. Finally, the surgeon must, once again, reposition her or his hand from the distal end of housing 18 to rotate foot actuation handle 26 in the other direction to the return foot 24 to its parked or collapsed position to permit removal of device 10. It would, therefore, be an improvement to provide a vessel closure device of the type described herein and that provides an improved ergonomic design that allows placement, actuation and removal without requiring the user to reposition her or his hands multiple times during the procedure.



FIGS. 10 through 12 illustrate another embodiment of an articulating suture device 110 that provides additional ease of use. Suture device 110 is similar in many respects to the embodiments illustrated and described above, and corresponding parts and features are labeled with correspondingly similar reference numerals.


One primary difference between the embodiment shown in FIGS. 1 through 14 and the embodiment of FIGS. 10 through 12 is the foot actuation handle 26. In FIGS. 1 through 14, foot actuation handle 26 is a lever that rotates about an axis that is oriented transverse with the longitudinal axis of device 10 and housing 18. As mentioned above, this design requires the surgeon to reposition her or his hands multiple times during the various steps of the procedure in order to deploy and retract the foot. As illustrated in FIGS. 10 through 12, foot actuation handle 126 consists of a pair of handles 126a and 126b that extend transversely from each side of housing 118 and move in a linear direction parallel with the longitudinal axis of housing 118. As illustrated, handles 126a and 126b can have a “trigger” configuration.


Another difference is in the operation of device 110. In particular, the embodiment makes it possible to place, actuate and remove device 110 in a substantially continuous series of actions without the need for the surgeon to reposition her or his hands in the process. As described in greater detail below, the surgeon may grasp the proximal end of housing 118 in one hand, by positioning her or his thumb on the proximal end of needle actuation handle 120 and positioning her or his index and middle fingers on foot actuation handles 126a and 126b (see FIG. 11A). In addition, the surgeon can hold and stabilize the distal end of housing 118 with the other hand. Once device 110 is properly positioned within the vessel, foot 124 is deployed by drawing foot actuation handles 126a and 126b in a proximal direction (see FIG. 11B). This is done simply by the user applying pressure between the proximal end of needle actuation handle 120 and foot actuation handles 126a and 126b, thereby drawing foot actuation handles 126a and 126b in a proximal direction relative to housing 118 and needle actuation handle 120. Once foot 124 is fully deployed, foot actuation handles 126a and 126b engage slots formed in the side of the housing to temporarily lock handles 126a and 126b into place relative to housing 118. Then, needles 138 can be deployed and advanced distally to engage foot 126 by simply applying additional pressure to needle actuation handle 120, thereby moving needle actuation handle 120 (and thus needles 138) in a distal direction relative to housing 118 (see FIG. 11C). Once needles 138 are fully advanced and engage fittings 140, the surgeon simply pulls needle actuation handle 120 in a proximal direction relative to housing 118 to draw needles 138, fittings 140 and suture 134 through the vessel wall and back into needle guides 154 (see FIG. 11D). Finally, as needle actuation handle 120 is withdrawn in the proximal direction, it automatically releases foot actuation handles 126a and 126b from their locked position, so that foot actuation handles 126a and 126b are free to return their original, starting position, thereby returning foot 124 to its parked or collapsed position (see FIG. 11D). And, all of the foregoing steps can be performed by the surgeon without having to reposition her or his hands during the entire procedure.


Referring to FIG. 12, the various components of this embodiment, and their interactions one with another, will be discussed in additional detail. Housing 118 has a bottom portion 118a and a top portion 118b. In FIG. 12, the top portion 118b has been removed and is not shown, so as to reveal various components housed within housing 118. Situated toward the distal end of housing 118 is a tensioner assembly 162 that applies a small, predetermined amount of tension to the foot actuation wire 132 when foot 124 is in a deployed position. Tensioner assembly 162 can include a sled 163 and a tensioner block 164. Sled 163 can have a rectangular portion 165, with a tensioner well 166 formed therein, and a pair of control arms 167a and 167b that extend from the proximal end of rectangular portion 165 and extend in a proximal direction. Control arms 167a and 167b can be coupled to foot actuation handle 126 in a manner described below. Tensioner block 164 and a bias spring 168 can be positioned within tensioner well 166. Tensioner block 164 can include a wire lumen 169 that extends longitudinally along the length of tensioner block 164 and is configured to receive a portion of the proximal end of foot actuation wire 132 in lumen 169. In this embodiment, foot actuation wire 132 is bonded to a portion of tensioner block 164 with a suitable bonding agent, glue or liquid cement. When the foot 124 is deployed, spring 168 is compressed a small amount between tensioner block 164 and the distal wall of tensioner well 166 to provide and maintain a small amount of tension on foot actuation wire 132 and thereby bias foot 124 to its deployed position.


Situated toward the proximal end of housing 118 is a connector assembly 172. Connector assembly 172 can include a connector 173, a follower 174 and a connector spring 175. Follower 174 can terminate at its distal end in a ball 176. Connector assembly 172 connects needle actuation handle 120 to the proximal ends of needles 138 at ball 176. As shown in FIG. 10, connector spring 175 is positioned between needle actuation handle 120 and the proximal end of housing 118 and biases needle actuation handle 120 towards its proximal, undeployed position. As further illustrated in FIG. 10, the housing can be provided with a pair of projections or fingers 196a and 196b that extend vertically from bottom housing 118a and engage opposite sides of ball 176 and on opposite sides of needles 138. Alternatively, projections 196 could also extend downward from top housing 118b, or from both bottom and top housings 118a and 118b. In any event, projections 196a and 196b initially prevent movement of needle actuation handle 120 in either direction by constraining ball 176 between projections 196a and 196b. However, projections 196a and 196b can be designed and configured to have a certain level of resilience, so that the application of a predetermined amount force to needle actuation handle 120 is required to and will cause projections 196a and/or 196b to either break or to flex to a sufficient degree to allow ball 176 to pass through, thereby allowing needle actuation handle 120 to move in a distal direction to deploy needles 138 and/or to move in a proximal direction to withdraw needles 138.


Situated between tensioner assembly 162 and connector assembly 172 is foot actuation handle 126, which forms a linkage between tensioner assembly 162 and connector assembly 172. As mentioned previously, foot actuation handle 126 can include a pair of handles 126a and 126b positioned on and extending laterally from oppositing sides of housing 118. Foot actuation handle 126 can also include a pair of arms 176a and 176b that extend along opposing sides of the exterior of housing 118. Arms 176a and 178b are connected at their proximal ends to handles 126a and 126b, respectively. The other ends of arms 176a and 176b extend through slots formed in opposing sides of housing 118 and connect to a central hub 177. Central hub 177 has a lumen 178 extending through the center, through which needles 138 and follower 174 can pass. Central hub 177 can also have a pair of recesses 179a and 179b that are configured to receive the proximal ends of control arms 167a and 167b, respectively, of sled 163. With control arms 167a and 167b positioned within recesses 179a and 179b, handles 126a and 126b and tensioner assembly 162 are coupled together so that they move together in either axial direction. When handles 126a and 126b are moved in a proximal direction, this causes tensioner assembly 162 to also move in a proximal direction, thereby deploying foot 124 from a parked position to a deployed position. Conversely, when handles 126a and 126b move in a distal direction, this causes tensioner assembly 162 to also move in a distal direction, thereby causing foot 124 to move from a deployed position to a parked position.


Foot actuation handle 126 can also include a pair of lock detents 180a and 180b, located at the proximal end and on the inner surface of arms 176a and 176b, respectively. When foot actuator handle 126 is moved proximally to its deployed position, lock detents 180a and 180b engage actuator locking windows 182a and 182b, respectively, which are formed on either side of housing 118, temporarily locking foot actuator handle 126 (and, thus, foot 124) in the deployed position. Foot actuator handle 126 remains locked in the deployed position while needle actuator handle 120 is moved in a distal direction, causing needles 138 to engage fittings 140. Then, as needle actuation handle 120, needles 138, fittings 140 and suture 134 are withdrawn in a proximal direction and removed from the tissue tract, a portion of needle actuation handle 120 engages the ends of lock dents 180a and 180b, thereby releasing them from locking windows 182a and 182b and allowing foot actuation handle 126 (and foot 124) to return to the parked position. A return spring 190 is positioned within housing between a flange 192 formed in bottom housing 118a and the proximal end of sled 163. Return spring 190 biases foot actuation handle 126 toward its original, distal and parked position.


The device 110 also includes a first interlock mechanism 188 that prevents needle actuation handle 120 and/or connector assembly 178 from moving relative to the housing, either in a proximal or distal direction, while foot 124 is in its initial parked position. Once foot 124 is moved to its deployed or expanded position, then first interlock 188 automatically releases needle actuation handle 120 and connector assembly 178 to move in a distal direction relative to the housing and thereby advance needles 138 in a distal direction to engage foot 124. Similarly, with foot 124 in its deployed position, first interlock 188 also permits needle actuation handle 120 and connector assembly 178 to be withdrawn in a proximal direction relative to housing 118 and thereby withdraw needles 138, fittings 140 and suture 134 through the vessel wall and through the tissue tract. In one embodiment, first interlock mechanism 188 can include ball 176 and projections 196a and 196b, which cooperate in the manner described above to perform the functionality of first interlock mechanism 188.


Device 10 also includes a second interlock mechanism 190 that locks foot actuation handle 126 in place when it foot actuation handle 126 is moved to its position to deploy foot 124 and to thereby maintain foot 124 in its deployed position while needles 138 are advanced distally to engage fittings 140 and then withdrawn proximally from the vessel wall and tissue tract. As discussed above, once needles 138 have been withdrawn in a proximal direction far enough that the distal ends of needles 138 have been completely withdrawn into needle guides 154, then second interlock mechanism 190 automatically released foot actuation handle 126 to return to its original position, thereby returning foot 124 to its parked or collapsed position. In one embodiment, second interlock mechanism 190 can include lock detents 180a and 180b and actuator locking windows 182a and 182b, which cooperate in the manner described above to perform the functionality of second interlock mechanism 190.


Yet an additional aspect and feature of the invention will now be discussed with reference to FIGS. 13 and 14. In some situations, such as when attempting to close a vessel puncture with a relatively large diameter, it may be desirable to apply multiple sutures across the same opening, but at different positions and/or orientations. To assist with the placement of sutures at different angular orientations relative to the puncture, the vessel closure devices described above can also include alignment markings positioned on the exterior adjacent the distal end of the proximal housing. For example, vessel closure devices 110 can also include one or more alignment marks, such as alignment marks 200a, 200b and 200c, as illustrated in FIG. 13. Alignment marks 200 provide a visual reference relative to the relative orientation of needles 138. In this particular embodiment, needles 138a and 138b are aligned with alignment mark 200a, such that when device 110 is rotated and oriented so that alignment mark 200a is positioned directly on top of handle 118 (i.e., vertically oriented), then the relative position of needles 138a and 138b would also be substantially vertically oriented relative to the axis 128 of shaft 112. Thus, when device 110 is rotated clockwise until alignment mark 200b is vertically oriented (i.e., is positioned at the twelve o'clock), then the relative position of needles 138a and 138b would be oriented at an approximately 60 degree angle relative to the vertical (oriented in the clockwise direction). Conversely, when device 110 is rotated counter-clockwise until alignment mark 200c is vertically oriented (i.e., is positioned at the twelve o'clock), then the relative position of needles 138a and 138b would be oriented at an approximately 60 degree angle relative to the vertical, but oriented in the counter-clockwise direction.


Thus, alignment marks 200 provide a visual guide to allow the surgeon to selectively and accurately locate one or more sutures across the vessel puncture at different angular orientations. In the case of multiple sutures, this would require a separate vessel closure device 110 for each suture. For example, if two sutures were desired at different angular positions, a first closure device 110 would be used to place a first suture across the vessel opening at a first angular orientation as graphically depicted in FIG. 14A. The first suture would be cut, but not tied, and then the first closure device is removed, leaving the guidewire in place. Then a second suture device 110 would be inserted over the guidewire and properly positioned within the same vessel opening. However, using one of the other the alignment marks, the second device would be positioned at a different angular orientation to place the second suture across the vessel opening at a second angular orientation (as graphically illustrated in FIG. 14B). Once the second device is removed, then both the first and second sutures could be tied, closing off the vessel puncture site. And, as indicated in FIG. 14C, this process could be extended as needed to provide a third suture.


In operation, a tissue suturing device is used by advancing a needle distally to penetrate the tissue and position a suture through the tissue. In various embodiments described herein, attaching the suture to the needle is accomplished by moving the needles distally through a housing of a device to connect to the suture. The suture is positioned through the tissue by withdrawing the needle proximally through the proximal end of the housing. Finally, the needle can be separated from the suture by drawing the suture across the suture cutting blade to sever the needle from the suture.


The various embodiments of a suturing device described herein can be provided to position a suture across an opening in a wall of a blood vessel to close the opening. In a femoral artery closure procedure, for example, such devices are used to advance the suture and the needle percutaneously through subcutaneous tissue to a blood vessel access site.


The present invention offers surgeons an automated method for delivering a pre-tied knot to an incision formed in a tissue wall. The present invention simplifies the effort associated with a surgeon manually delivering a knot to an incision site. Thus, the present invention reduces the time required to accurately and precisely place a suture knot in close proximity to an incision formed in a lumen, thereby decreasing both the overall time a patient spends in procedure and recovery and the costs associated therewith.


While the exemplary embodiments have been described in some detail for clarity of understanding, a wide variety of modifications, adaptations, and changes will be apparent to those of skill in the art. Hence, the scope of the present invention is limited solely by the appended claims.

Claims
  • 1. An improved actuation and control mechanism intended for use in a vessel closure device for closing an opening or puncture in a vessel wall having an elongate shaft having a longitudinal axis, a housing positioned at the proximal end of the shaft, a flexible, atraumatic monorail guidebody positioned at the distal end of the shaft, a foot articulatably mounted proximate the distal end of the shaft, the foot being movable between a first, parked position, in which the foot is substantially aligned along the axis of the shaft, and a second, deployed position, in which the foot extends laterally away from the shaft, the foot having a first and a second end, the first end and the second end each having a needle receptacle with a cuff positioned therein, a length of suture located within the foot and extending between the cuffs, and a pair of needles located within the shaft that can be selectively advanced through the vessel wall adjacent to the opening and into the cuffs located in the needle receptacles in the first and second ends of the foot, and that can be selectively withdrawn thereby drawing the suture through the vessel wall adjacent to the opening, the improved actuation and control mechanism for the vessel closure device comprising: a foot actuation handle operatively coupled to the foot, the foot actuation handle being selectively moveable linearly along the axis of the device between a distal position whereby the foot is positioned in its first, parked position, and a proximal position whereby the foot is positioned in its second, deployed position, the foot actuation handle comprising a pair of handles that extend laterally from opposing sides of the housing, and wherein the foot actuation handle is configured to be grasped and manipulated by a pair of fingers of one hand of a user; anda needle actuation handle operatively coupled to the needles, the needle actuation handle being selectively movably linearly along the axis of the device between a proximal position wherein the needles are located within the shaft and a distal position wherein the needles are advanced to engage the cuffs, and wherein the needle actuation handle is configured to be engaged and selectively manipulated by a thumb of the same one hand of the user.
  • 2. The vessel closure device of claim 1, wherein the foot is deployed by axial movement of the foot actuation handle in the proximal direction relative to the needle actuation handle.
  • 3. The vessel closure device of claim 2, wherein, once the foot is deployed by proximal movement of the foot actuation handle, the needles are deployed into engagement with the foot by axial movement of the needle actuation handle in the distal direction relative to the foot actuation handle.
  • 4. The vessel closure device of claim 1 further comprising a first interlock mechanism that prevents the needle actuation handle from being advanced from its proximal position when the foot is positioned in its first, parked position, but allows the needle actuation handle to be advanced from its proximal position to its distal position after the foot is moved to its second, deployed position.
  • 5. The vessel closure device of claim 4, wherein the first interlock mechanism comprises: a ball formed on a distal end of the needle actuation handle; anda pair of projections formed on the housing and engaging opposing sides of the ball to constrain movement of the ball until a predetermined amount of pressure is applied to the needle actuation handle force the ball past the projection.
  • 6. The vessel closure device of claim 5, wherein projections are flexible and resilient and are configured bend upon application of the predetermined amount of pressure applied to the needle actuation handle to allow movement of the ball in the distal direction.
  • 7. The vessel closure device of claim 5, wherein projections are configured break upon application of the predetermined amount of pressure applied to the needle actuation handle to allow movement of the ball in the distal direction.
  • 8. The vessel closure device of claim 1 further comprising a second interlock mechanism that temporarily locks the foot actuation handle into place when it is moved from its distal position to its proximal position.
  • 9. The vessel closure device of claim 8 wherein the second interlock mechanism automatically releases the foot actuation handle from its proximal position after the needle actuation handle is returned to its proximal position from its distal position.
  • 10. The vessel closure device of claim 9 further comprising a return bias spring associated with the foot actuation handle for biasing the foot actuation handle toward its distal position.
  • 11. The vessel closure device of claim 10, wherein the second interlock mechanism comprises: a pair of lock detents positioned on an inner surface of the foot actuation handle;a pair of lock windows formed in opposing sides of the housing and positioned so as to receive the lock detents when the foot actuation handle is moved to its proximal position and thereby temporarily lock the foot actuation handle in its proximal position; anda pair of flanges formed on an inner portion of the needle actuation handle, the flanges being configured to engage the lock detents and release the lock detents from the lock windows as the needle actuation handle is withdrawn from its distal position to its proximal position.
  • 12. The vessel closure device of claim 1 further comprising one or more alignment marks positioned on an exterior surface of a distal end of the housing, each alignment mark being located at a pre-selected rotational position relative to the needles.
  • 13. The vessel closure device of claim 12, wherein a first one of the one or more alignment marks is vertically aligned with the needles.
  • 14. The vessel closure device of claim 13, wherein a second one of the one or more alignment marks is located at an angle of about 60 degrees in a clockwise direction relative to the first one of the one or more alignment marks.
  • 15. The vessel closure device of claim 14, wherein a third one of the one or more alignment marks is located at an angle of about 60 degrees in a counter-clockwise direction relative to the first one of the one or more alignment marks.
US Referenced Citations (580)
Number Name Date Kind
312408 Wackerhagen Feb 1885 A
597165 Hall Jan 1898 A
659422 Shidler Oct 1900 A
989231 Davis Apr 1911 A
1574362 Callahan Sep 1922 A
1625602 Gould et al. Apr 1927 A
1940351 Howard Mar 1933 A
2012776 Roeder Aug 1935 A
2131321 Hart Oct 1937 A
2127903 Bowen Aug 1938 A
2371978 Perham Mar 1945 A
2397823 Walter Apr 1946 A
RE22857 Ogburn Mar 1947 E
2595086 Larzelere Nov 1948 A
2588589 Tauber Mar 1952 A
2646045 Priestley Jul 1953 A
2692599 Creelman Oct 1954 A
2941489 Fischbein Jun 1960 A
2959172 Held Nov 1960 A
3033156 Verlish May 1962 A
3104666 Hale et al. Sep 1963 A
3197102 Bates et al. Jul 1965 A
3359983 Northey Dec 1967 A
3413397 Bierbaum et al. Nov 1968 A
3422181 Chirgwin, Jr. Jan 1969 A
3470875 Johnson Oct 1969 A
3485234 Stevens Dec 1969 A
3587115 Shiley Jun 1971 A
3630205 Listner Dec 1971 A
3653388 Tenckhoff Apr 1972 A
3665926 Flores May 1972 A
3776237 Hill et al. Dec 1973 A
3802438 Wolvek Apr 1974 A
3820544 Semm Jun 1974 A
3840017 Violante Oct 1974 A
3874388 King et al. Apr 1975 A
3878848 Hiebert Apr 1975 A
3918455 Coplan Nov 1975 A
3926194 Greenberg et al. Dec 1975 A
3939820 Grayzel Feb 1976 A
3985138 Jarvik Oct 1976 A
4018228 Goosen Apr 1977 A
4069825 Akiyama Jan 1978 A
4109658 Hughes Aug 1978 A
4128100 Wendorff Dec 1978 A
4135623 Thyen Jan 1979 A
4161951 Scanlan, Jr. Jul 1979 A
4168073 LaRue Sep 1979 A
4182339 Hardy, Jr. Jan 1980 A
4185636 Gabbay et al. Jan 1980 A
4216776 Downie et al. Aug 1980 A
4217665 Bex et al. Aug 1980 A
4235177 Arbuckle Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4316469 Kapitanov Feb 1982 A
4317445 Robinson Mar 1982 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4437465 Nomoto et al. Mar 1984 A
4469101 Coleman et al. Sep 1984 A
4492229 Grunwald Jan 1985 A
4493323 Albright et al. Jan 1985 A
4553543 Amarasinghe Nov 1985 A
4580566 Hsu Apr 1986 A
4586614 Ger May 1986 A
4587969 Gillis May 1986 A
4596559 Fleishhacker Jun 1986 A
4610248 Rosenberg Sep 1986 A
4629450 Suzuki et al. Dec 1986 A
4651733 Mobin-Uddin Mar 1987 A
4655211 Sakamoto et al. Apr 1987 A
4702250 Orvil et al. Oct 1987 A
4723549 Wholey et al. Feb 1988 A
4738666 Fuqua Apr 1988 A
4744364 Kensey May 1988 A
4748982 Horzewski et al. Jun 1988 A
4782954 Reynolds Nov 1988 A
4803984 Narayanan et al. Feb 1989 A
4823794 Pierce Apr 1989 A
4836205 Barrett Jun 1989 A
4845851 Warthen Jul 1989 A
4848341 Ahmad Jul 1989 A
4852568 Kensey Aug 1989 A
4890612 Kensey Jan 1990 A
4898155 Ovil et al. Feb 1990 A
4911164 Roth Mar 1990 A
4917089 Sideris Apr 1990 A
4926860 Stice et al. May 1990 A
4929246 Sinofsky May 1990 A
4935027 Yo on Jun 1990 A
4950285 Wilk Aug 1990 A
4957498 Caspari et al. Sep 1990 A
4966600 Songer et al. Oct 1990 A
4981149 Yoon et al. Jan 1991 A
4983168 Moorehead Jan 1991 A
4984581 Stice Jan 1991 A
5002563 Pyka et al. Mar 1991 A
5009643 Reich et al. Apr 1991 A
5021059 Kensey et al. Jun 1991 A
5037433 Wilk et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5047039 Avant et al. Sep 1991 A
5059201 Asnis Oct 1991 A
5061274 Kensey Oct 1991 A
5074874 Yoon et al. Dec 1991 A
5078721 McKeating Jan 1992 A
5080664 Jain Jan 1992 A
5100419 Ehlers Mar 1992 A
5100422 Berguer et al. Mar 1992 A
5100432 Matsutani Mar 1992 A
5108421 Fowler Apr 1992 A
5109780 Slouf et al. May 1992 A
5129882 Weldon et al. Jul 1992 A
5129912 Noda et al. Jul 1992 A
5129913 Ruppert Jul 1992 A
5144961 Chen et al. Sep 1992 A
5147373 Ferzli Sep 1992 A
5156788 Chesterfield et al. Oct 1992 A
5160339 Chen et al. Nov 1992 A
5163946 Li Nov 1992 A
5169041 Tan Dec 1992 A
5171251 Bregen et al. Dec 1992 A
5176691 Pierce Jan 1993 A
5178629 Kammerer Jan 1993 A
5192294 Blake, III Mar 1993 A
5192301 Kamiya et al. Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5201744 Jones Apr 1993 A
5207703 Jain May 1993 A
5211650 Noda May 1993 A
5217470 Weston Jun 1993 A
5217485 Liv et al. Jun 1993 A
5219358 Bendel et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5234443 Phan et al. Aug 1993 A
5234445 Walker et al. Aug 1993 A
5237985 Hodgson et al. Aug 1993 A
5242427 Bilweis Sep 1993 A
5250033 Evans Oct 1993 A
5250053 Snyder Oct 1993 A
5250054 Li Oct 1993 A
5254105 Haaga Oct 1993 A
5254113 Wilk Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5258003 Ciaglia et al. Nov 1993 A
5259846 Granger et al. Nov 1993 A
5275616 Fowler Jan 1994 A
5279311 Snyder Jan 1994 A
5281236 Bognato et al. Jan 1994 A
5281237 Gimpelson Jan 1994 A
5284485 Kammerer et al. Feb 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290284 Adair Mar 1994 A
5290297 Phillips Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292309 VanTassel et al. Mar 1994 A
5292327 Dodd et al. Mar 1994 A
5292332 Lee Mar 1994 A
5293881 Green et al. Mar 1994 A
5295993 Green Mar 1994 A
5300085 Yock Apr 1994 A
5304184 Hathaway et al. Apr 1994 A
5304185 Taylor Apr 1994 A
5306254 Nash et al. Apr 1994 A
5312024 Grant et al. May 1994 A
5312423 Rosenbluth et al. May 1994 A
5318578 Hasson Jun 1994 A
5320629 Noda et al. Jun 1994 A
5320632 Heidmueller Jun 1994 A
5330445 Haaga Jul 1994 A
5330491 Walker et al. Jul 1994 A
5334217 Das Aug 1994 A
5336229 Noda Aug 1994 A
5336230 Leichtling et al. Aug 1994 A
5336231 Adair Aug 1994 A
5342369 Harryman, II Aug 1994 A
5353974 Maurizio Oct 1994 A
5354312 Brinkerhoff et al. Oct 1994 A
5364407 Poll Nov 1994 A
5364408 Gordon Nov 1994 A
5368595 Lewis Nov 1994 A
5368601 Sauer et al. Nov 1994 A
5374275 Bradley et al. Dec 1994 A
5374278 Chesterfield et al. Dec 1994 A
5376096 Foster Dec 1994 A
5383896 Gershony et al. Jan 1995 A
5383905 Golds et al. Jan 1995 A
5385569 Swor Jan 1995 A
5387221 Bisgaard Feb 1995 A
5387227 Grice Feb 1995 A
5391176 de la Torre Feb 1995 A
5391182 Chin Feb 1995 A
5395332 Ressemann et al. Mar 1995 A
5395349 Quiachon et al. Mar 1995 A
5397310 Chu et al. Mar 1995 A
5397325 Delia Badia et al. Mar 1995 A
5397326 Mangum Mar 1995 A
5403329 Hinchcliffe Apr 1995 A
5403331 Chesterfield et al. Apr 1995 A
5403338 Milo Apr 1995 A
5405352 Weston Apr 1995 A
5411481 Allen et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5417684 Jackson et al. May 1995 A
5417699 Klein et al. May 1995 A
5419765 Weldon et al. May 1995 A
5425705 Evard et al. Jun 1995 A
5425737 Burbank et al. Jun 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5431666 Sauer et al. Jul 1995 A
5433700 Peters Jul 1995 A
5452733 Sterman et al. Sep 1995 A
5454822 Schob et al. Oct 1995 A
5454834 Boebel et al. Oct 1995 A
5458574 Machold et al. Oct 1995 A
5458609 Gordon et al. Oct 1995 A
5462560 Stevens Oct 1995 A
5462561 Voda Oct 1995 A
5464426 Bonutti Nov 1995 A
5466241 Leroy et al. Nov 1995 A
5470338 Whitfield et al. Nov 1995 A
5474568 Scott Dec 1995 A
5476469 Hathaway et al. Dec 1995 A
5476470 Fitzgibbons, Jr. Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5480407 Wan et al. Jan 1996 A
5486190 Green Jan 1996 A
5489295 Piplani et al. Feb 1996 A
5496332 Sierra et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5507757 Sauer et al. Apr 1996 A
5507758 Thomason et al. Apr 1996 A
5509902 Raulerson Apr 1996 A
5520655 Davila et al. May 1996 A
5520665 Fleetwood May 1996 A
5520691 Branch May 1996 A
5520702 Sauer et al. May 1996 A
5527321 Hinchliffe Jun 1996 A
5527322 Klein et al. Jun 1996 A
D372310 Hartnett Jul 1996 S
5531700 Moore et al. Jul 1996 A
5536273 Lehrer Jul 1996 A
5540701 Sharkey et al. Jul 1996 A
5540703 Barker, Jr. et al. Jul 1996 A
5540704 Gordon et al. Jul 1996 A
5545171 Sharkey et al. Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5549618 Fleenor et al. Aug 1996 A
5549631 Bonutti Aug 1996 A
5554162 DeLange Sep 1996 A
5562684 Kammerer Oct 1996 A
5562686 Sauer et al. Oct 1996 A
5562688 Riza Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5567435 Hubbell et al. Oct 1996 A
5569269 Hart et al. Oct 1996 A
5569271 Hoel Oct 1996 A
5571120 Yoon Nov 1996 A
5573540 Yoon Nov 1996 A
5578044 Gordon et al. Nov 1996 A
5584842 Fogarty et al. Dec 1996 A
5591177 Lehrer Jan 1997 A
5591179 Edelstein Jan 1997 A
5591206 Moufarrege Jan 1997 A
5593421 Bauer Jan 1997 A
5601572 Middleman et al. Feb 1997 A
5603718 Xu Feb 1997 A
5607435 Sachdeva et al. Mar 1997 A
5609597 Lehrer Mar 1997 A
5611794 Sauer et al. Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5613975 Christy Mar 1997 A
5624446 Harryman, II Apr 1997 A
5626588 Sauer et al. May 1997 A
5643289 Sauer et al. Jul 1997 A
5643295 Yoon Jul 1997 A
5643318 Tsukernik et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
5662664 Gordon et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5676689 Kensey et al. Oct 1997 A
5700273 Buelna et al. Dec 1997 A
5707379 Fleenor et al. Jan 1998 A
5713910 Gordon et al. Feb 1998 A
5716369 Riza Feb 1998 A
5720574 Barella Feb 1998 A
5720757 Hathaway et al. Feb 1998 A
5722981 Stevens Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5728109 Schulze et al. Mar 1998 A
5728114 Evans et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5741276 Poloyko et al. Apr 1998 A
5741280 Fleenor Apr 1998 A
5746755 Wood et al. May 1998 A
5749890 Shaknovich May 1998 A
5755727 Kontos May 1998 A
5759188 Yoon Jun 1998 A
5766183 Sauer Jun 1998 A
5766186 Faraz et al. Jun 1998 A
5766217 Christy Jun 1998 A
5769862 Kammerer et al. Jun 1998 A
5779719 Klein et al. Jul 1998 A
5782860 Epstein et al. Jul 1998 A
5782861 Cragg et al. Jul 1998 A
5792151 Heck et al. Aug 1998 A
5792152 Klein et al. Aug 1998 A
5797928 Kogasaka Aug 1998 A
5797929 Andreas et al. Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810850 Hathaway et al. Sep 1998 A
5810884 Kim Sep 1998 A
5814069 Schulze et al. Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5820631 Nobles Oct 1998 A
5824010 McDonald Oct 1998 A
5824111 Schall et al. Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5836315 Benderev et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5836956 Buelna et al. Nov 1998 A
5846253 Buelna et al. Dec 1998 A
5848714 Robson et al. Dec 1998 A
5855585 Kontos Jan 1999 A
5860963 Azam et al. Jan 1999 A
5860990 Nobles et al. Jan 1999 A
5860991 Klein et al. Jan 1999 A
5861005 Kontos Jan 1999 A
5871490 Schulze et al. Feb 1999 A
5871502 Suryadevara Feb 1999 A
5873876 Christy Feb 1999 A
5876411 Kontos Mar 1999 A
5895404 Ruiz Apr 1999 A
5897487 Ouchi Apr 1999 A
5897564 Schulze et al. Apr 1999 A
5902311 Andreas et al. May 1999 A
5904597 Doi et al. May 1999 A
5904690 Middleman et al. May 1999 A
5904697 Gifford, III et al. May 1999 A
5906631 Imran May 1999 A
5919207 Taheri Jul 1999 A
5921994 Andreas et al. Jul 1999 A
5928266 Kontos Jul 1999 A
5951590 Goldfarb Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957936 Yoon et al. Sep 1999 A
5957937 Yoon Sep 1999 A
5957938 Zhu et al. Sep 1999 A
5964773 Greenstein Oct 1999 A
5964782 Lafontaine et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5976161 Kirsch et al. Nov 1999 A
5980539 Kontos Nov 1999 A
5997555 Kontos Dec 1999 A
6001109 Kontos Dec 1999 A
6022372 Kontos Feb 2000 A
6024747 Kontos Feb 2000 A
6036699 Andreas Mar 2000 A
6042601 Smith Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6048354 Lawrence Apr 2000 A
6048357 Kontos Apr 2000 A
6059800 Hart et al. May 2000 A
6068603 Suzuki May 2000 A
6077276 Kontos Jun 2000 A
6077279 Kontos Jun 2000 A
6102920 Sullivan et al. Aug 2000 A
6117144 Nobles et al. Sep 2000 A
6117145 Wood et al. Sep 2000 A
6126675 Shchervinsky et al. Oct 2000 A
6132439 Kontos Oct 2000 A
6132440 Hathaway et al. Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6139556 Kontos Oct 2000 A
6152936 Christy et al. Nov 2000 A
6165183 Kuehn et al. Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6190396 Whitin et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6206895 Levinson Mar 2001 B1
6245079 Nobles et al. Jun 2001 B1
6248124 Pedros et al. Jun 2001 B1
6296657 Brucker Oct 2001 B1
6302870 Jacobsen et al. Oct 2001 B1
6346111 Gordon et al. Feb 2002 B1
6348059 Hathaway et al. Feb 2002 B1
6355050 Andreas et al. Mar 2002 B1
6358258 Arcia et al. Mar 2002 B1
6395015 Borst et al. May 2002 B1
6428472 Haas Aug 2002 B1
6428549 Kontos Aug 2002 B1
6436109 Kontos Aug 2002 B1
6443963 Baldwin et al. Sep 2002 B1
6451031 Kontos Sep 2002 B1
6511489 Field et al. Jan 2003 B2
6517553 Klein et al. Feb 2003 B2
6533812 Swanson et al. Mar 2003 B2
6551329 Kortenbach et al. Apr 2003 B1
6551330 Bain et al. Apr 2003 B1
6558399 Isbell et al. May 2003 B1
6562052 Nobles et al. May 2003 B2
6569185 Ungs May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6610072 Christy et al. Aug 2003 B1
6623509 Ginn Sep 2003 B2
6623510 Carley et al. Sep 2003 B2
6632237 Ben-David et al. Oct 2003 B2
6641592 Sauer et al. Nov 2003 B1
6663655 Ginn et al. Dec 2003 B2
6676685 Pedros et al. Jan 2004 B2
6695867 Ginn et al. Feb 2004 B2
6716228 Tal Apr 2004 B2
6743195 Zucker Jun 2004 B2
6743259 Ginn Jun 2004 B2
6749621 Pantages et al. Jun 2004 B2
6749622 McGuckin, Jr. et al. Jun 2004 B2
6837906 Ginn Jan 2005 B2
6846319 Ginn et al. Jan 2005 B2
6890343 Ginn et al. May 2005 B2
6896692 Ginn et al. May 2005 B2
6911034 Nobles et al. Jun 2005 B2
6936054 Chu Aug 2005 B2
6939357 Navarro et al. Sep 2005 B2
6955643 Gellman et al. Oct 2005 B2
6964668 Modesitt et al. Nov 2005 B2
6969371 Palasis et al. Nov 2005 B2
6969397 Ginn Nov 2005 B2
6997932 Dreyfuss et al. Feb 2006 B2
7001400 Modesitt et al. Feb 2006 B1
7029480 Klein et al. Apr 2006 B2
7029481 Burdulis, Jr. et al. Apr 2006 B1
7033370 Gordon et al. Apr 2006 B2
7048747 Arcia et al. May 2006 B2
7063710 Takamoto Jun 2006 B2
7066077 Schnapp et al. Jun 2006 B2
7083635 Ginn Aug 2006 B2
7108710 Anderson Sep 2006 B2
7112225 Ginn Sep 2006 B2
7131980 Field et al. Nov 2006 B1
7160309 Voss Jan 2007 B2
7179266 Kontos Feb 2007 B2
7229458 Boecker et al. Jun 2007 B2
7235087 Modesitt et al. Jun 2007 B2
7316704 Bagaoisan et al. Jan 2008 B2
7326230 Ravikumar Feb 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7335220 Khosravi et al. Feb 2008 B2
7361183 Ginn Apr 2008 B2
7361185 O'Malley et al. Apr 2008 B2
7377927 Burdulis, Jr. et al. May 2008 B2
7390328 Modesitt Jun 2008 B2
7393363 Ginn Jul 2008 B2
7442198 Gellman et al. Oct 2008 B2
7445626 Songer et al. Nov 2008 B2
7449024 Stafford Nov 2008 B2
7462188 McIntosh Dec 2008 B2
7753923 St. Goar et al. Jul 2010 B2
7833235 Chu Nov 2010 B2
7837696 Modesitt et al. Nov 2010 B2
7842047 Modesitt et al. Nov 2010 B2
7842048 Ma Nov 2010 B2
7842049 Voss Nov 2010 B2
7846170 Modesitt et al. Dec 2010 B2
7850701 Modesitt Dec 2010 B2
7883517 Pantages et al. Feb 2011 B2
7935128 Rioux et al. May 2011 B2
7967832 Chu Jun 2011 B2
8038688 Modesitt et al. Oct 2011 B2
8048092 Modesitt et al. Nov 2011 B2
8057491 Modesitt et al. Nov 2011 B2
8083754 Pantages et al. Dec 2011 B2
8123762 Chu et al. Feb 2012 B2
8137364 Zung et al. Mar 2012 B2
8172860 Zung et al. May 2012 B2
8202281 Voss Jun 2012 B2
8211122 McIntosh Jul 2012 B2
8252008 Ma Aug 2012 B2
8257368 McIntosh Sep 2012 B2
8267947 Pantages et al. Sep 2012 B2
8313498 Pantages et al. Nov 2012 B2
8323298 Modesitt et al. Dec 2012 B2
8361088 McIntosh Jan 2013 B2
8419753 Stafford Apr 2013 B2
8430893 Ma Apr 2013 B2
8512375 Torrie et al. Aug 2013 B2
8574244 Reynolds Nov 2013 B2
8597309 Stafford Dec 2013 B2
8663248 Zung et al. Mar 2014 B2
8663252 Fortson Mar 2014 B2
8858573 Fortson et al. Oct 2014 B2
8864778 Fortson et al. Oct 2014 B2
8998932 Voss Apr 2015 B2
9155535 McIntosh Oct 2015 B2
9241707 Roorda et al. Jan 2016 B2
9282960 Ma Mar 2016 B2
9301747 Zung et al. Apr 2016 B2
9370353 Fortson et al. Jun 2016 B2
9375211 Stafford Jun 2016 B2
9592038 Pantages et al. Mar 2017 B2
9820730 Chu Nov 2017 B2
20010046518 Sawhney Nov 2001 A1
20020045908 Nobles et al. Apr 2002 A1
20020095164 Andreas et al. Jul 2002 A1
20020099389 Michler et al. Jul 2002 A1
20020106409 Sawhney et al. Aug 2002 A1
20020107531 Schreck et al. Aug 2002 A1
20020177876 Roby et al. Nov 2002 A1
20030093093 Modesitt et al. May 2003 A1
20030171764 Debbas Sep 2003 A1
20030195529 Takamoto et al. Oct 2003 A1
20040009205 Sawhney Jan 2004 A1
20040092964 Modesitt et al. May 2004 A1
20040093027 Fabisiak et al. May 2004 A1
20040097978 Modesitt et al. May 2004 A1
20040127940 Ginn et al. Jul 2004 A1
20040143290 Brightbill Jul 2004 A1
20040158127 Okada Aug 2004 A1
20040158287 Cragg et al. Aug 2004 A1
20040167511 Buehlmann et al. Aug 2004 A1
20040181238 Zarbatany et al. Sep 2004 A1
20040186487 Klein et al. Sep 2004 A1
20040191277 Sawhney et al. Sep 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040225301 Roop et al. Nov 2004 A1
20040267193 Bagaoisan et al. Dec 2004 A1
20040267308 Bagaoisan et al. Dec 2004 A1
20050070923 McIntosh Mar 2005 A1
20050075665 Brenzel et al. Apr 2005 A1
20050085851 Fiehler et al. Apr 2005 A1
20050085854 Ginn Apr 2005 A1
20050085855 Forsberg Apr 2005 A1
20050121042 Belhe et al. Jun 2005 A1
20050149117 Khosravi et al. Jul 2005 A1
20050177189 Ginn et al. Aug 2005 A1
20050222614 Ginn et al. Oct 2005 A1
20050245876 Khosravi et al. Nov 2005 A1
20050267528 Ginn et al. Dec 2005 A1
20050273137 Ginn Dec 2005 A1
20060034930 Khosravi et al. Feb 2006 A1
20060047313 Khanna et al. Mar 2006 A1
20060069397 Nobles et al. Mar 2006 A1
20060100664 Pai et al. May 2006 A1
20060167477 Arcia et al. Jul 2006 A1
20060173469 Klein Aug 2006 A1
20060253037 Ginn et al. Nov 2006 A1
20060253072 Pai et al. Nov 2006 A1
20070005079 Zarbatany et al. Jan 2007 A1
20070032801 Pantages et al. Feb 2007 A1
20070060950 Khosravi et al. Mar 2007 A1
20070123817 Khosravi et al. May 2007 A1
20070282354 McIntosh Dec 2007 A1
20080009794 Bagaoisan et al. Jan 2008 A1
20080065151 Ginn Mar 2008 A1
20080065152 Carley Mar 2008 A1
20080287967 Andreas et al. Nov 2008 A1
20110071567 Modesitt et al. Mar 2011 A1
20110190793 Nobles et al. Aug 2011 A1
20110288563 Gianotti et al. Nov 2011 A1
20120016383 Sauer et al. Jan 2012 A1
20120150201 Pantages et al. Jun 2012 A1
20120283749 Sauer Nov 2012 A1
20130012962 Stone Jan 2013 A1
20140236189 Melsheimer et al. Aug 2014 A1
20150025551 Fortson et al. Jan 2015 A1
20150119906 Bagaoisan et al. Apr 2015 A1
20150273186 Voss Oct 2015 A1
20160135803 McIntosh May 2016 A1
20160135805 Roorda et al. May 2016 A1
20160192914 Ma Jul 2016 A1
20160287229 Zung et al. Oct 2016 A1
20160367234 Fortson et al. Dec 2016 A1
20160367241 Stafford Dec 2016 A1
20180338759 Roorda et al. Nov 2018 A1
Foreign Referenced Citations (81)
Number Date Country
912619 May 1954 DE
4210724 Jul 1993 DE
9217932 Jul 1993 DE
4220283 Dec 1993 DE
10211360 Oct 2003 DE
0 140 557 May 1985 EP
0 207 545 Jan 1987 EP
0 474 887 Mar 1992 EP
0 478 358 Apr 1992 EP
0 478 887 Apr 1992 EP
0 542 126 May 1993 EP
0 568 098 Nov 1993 EP
0 589 409 Mar 1994 EP
0 624 343 Nov 1994 EP
0 669 101 Aug 1995 EP
0 669 102 Aug 1995 EP
0 669 103 Aug 1995 EP
0 684 012 Nov 1995 EP
0 812 571 Dec 1997 EP
0 941 698 Sep 1999 EP
1059544 Mar 1954 FR
2768324 Mar 1999 FR
51143386 Nov 1976 JP
5220794 Feb 1977 JP
2119866 May 1990 JP
542161 Feb 1993 JP
820810 Apr 1981 SU
993922 Feb 1983 SU
1093329 May 1984 SU
1174036 Aug 1985 SU
1544383 Feb 1990 SU
1648400 May 1991 SU
WO 8503858 Sep 1985 WO
WO 0135833 Feb 1994 WO
WO 9405213 Mar 1994 WO
WO 9413211 Jun 1994 WO
WO 9427503 Dec 1994 WO
WO 9428801 Dec 1994 WO
WO 9505121 Feb 1995 WO
WO 9513021 May 1995 WO
WO 9525468 Sep 1995 WO
WO 9535065 Dec 1995 WO
WO 9609006 Mar 1996 WO
WO 9700046 Jan 1997 WO
WO 9703613 Feb 1997 WO
WO 9707745 Mar 1997 WO
WO 9710764 Mar 1997 WO
WO 9713461 Apr 1997 WO
WO 9717901 May 1997 WO
WO 9720505 Jun 1997 WO
WO 9727897 Aug 1997 WO
WO 9804195 Feb 1998 WO
WO 9842262 Oct 1998 WO
WO 9947049 Sep 1999 WO
WO 0012013 Mar 2000 WO
WO 0051498 Sep 2000 WO
WO 0069342 Nov 2000 WO
WO 0119259 Mar 2001 WO
WO 02036021 May 2002 WO
WO 02062234 Aug 2002 WO
WO 03003925 Jan 2003 WO
WO 03094748 Nov 2003 WO
WO 03099134 Dec 2003 WO
WO 05000126 Jan 2005 WO
WO 05023119 Mar 2005 WO
WO 05025430 Mar 2005 WO
WO 05030060 Apr 2005 WO
WO 05041782 May 2005 WO
WO 05063129 Jul 2005 WO
WO 05065549 Jul 2005 WO
WO 05092204 Oct 2005 WO
WO 05112782 Dec 2005 WO
WO 06026116 Mar 2006 WO
WO 06052611 May 2006 WO
WO 06052612 May 2006 WO
WO 06078578 Jul 2006 WO
WO 06115901 Nov 2006 WO
WO 06115904 Nov 2006 WO
WO 06118877 Nov 2006 WO
WO 07019016 Feb 2007 WO
WO 07081836 Jul 2007 WO
Non-Patent Literature Citations (285)
Entry
US 5,820,544 A, 06/1974, Semm (withdrawn)
U.S. Appl. No. 14/511,730, Oct. 13, 2017, Office Action.
U.S. Appl. No. 14/511,730, Jun. 11, 2018, Office Action.
U.S. Appl. No. 14/511,730, Oct. 31, 2018, Interview Summary.
U.S. Appl. No. 14/674,756, Jul. 6, 2017, Office Action.
U.S. Appl. No. 14/674,756, Sep. 18, 2017, Notice of Allowance.
U.S. Appl. No. 14/880,894, Oct. 31, 2017, Office Action.
U.S. Appl. No. 14/880,894, Apr. 2, 2018, Office Action.
U.S. Appl. No. 14/880,894, Aug. 6, 2018, Office Action.
U.S. Appl. No. 14/880,894, Nov. 21, 2018, Notice of Allowance.
U.S. Appl. No. 15/005,880, Nov. 13, 2017, Office Action.
U.S. Appl. No. 15/005,880, Apr. 10, 2018, Office Action.
U.S. Appl. No. 15/005,880, Jun. 20, 2018, Interview Summary.
U.S. Appl. No. 15/005,880, Jul. 13, 2018, Notice of Allowance.
U.S. Appl. No. 15/069,515, Mar. 20, 2018, Notice of Allowance.
U.S. Appl. No. 15/090,150, Dec. 12, 2018, Office Action.
U.S. Appl. No. 15/186,730, Sep. 5, 2018, Office Action.
U.S. Appl. No. 15/192,481, Jul. 20, 2018, Office Action.
U.S. Appl. No. 15/192,481, Oct. 31, 2018, Interview Summary.
U.S. Appl. No. 15/192,481, Jan. 11, 2019, Office Action.
U.S. Appl. No. 60/540,811, Jan. 30, 2004, McIntosh.
U.S. Appl. No. 60/946,063, Jun. 25, 2007, Reynolds.
U.S. Appl. No. 90/006,469, Nov. 29, 2002, Modesitt et al.
Cardiac Catheterization and Angiography, 3rd Ed., Lea & Febiger, Philadelphia, pp. 1-49, 52-247. 1986.
Cardio-Thoracic Systems Prospectus dated Mar. 20, 1996. pp. 1-4, 25-40.
Datascope Corporation, Montvale, NJ, Nov. 1991; 1 PG, American Heart Assoc. Meeting, Anaheim.
Elgiloy Brochure, Jun. 23, 1959; Elgin National Watch Co., Elgin, IL.
Kensey Nash Corporation, Exton, PA, “The Hemostatic Puncture Closure Device”, retrieved Oct. 23, 2007, 2 pages.
Laurus Medical Corporation, “Endoscopic Suturing Made Simple,” The Laurus ND-2600 Needle Driver, Irvine, CA., Oct. 1994, 1 page.
Marshall, A.C. & Lock, J.E.; “Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure”, Am. Heart Journ., 140(2):303-307, Aug. 2000.
Nakamura, S. et al., Techniques for Palmaz-Schatz Stent Deployment in Lesions With a Large Side Branch, Catheterization and Cardiovascular Diagnosis, 34: 353-361, 1995.
Definition of “pair”, Dictionary.com, accessed on May 5, 2014.
Product Brochure, “SuperStitch—Closure Made SimpleTM”, Sutura, Inc. (2003).
Product Brochure, Laurus Medical Corporation, Irvine, CA “The Laurus In-Line Endoscopic Suturing Device” (Oct. 1994) 1 page.
Rema-Medizintcchnik GmbH, Product Brochure entitled “REMA,” Apr. 2001, 7 pages.
Serruys, PW et al., A Comparision of Balloon-Expandable-Stent Implantation With Balloon Angioplasty in Patients With Coronary Artery Disease, New England Journal of Medicine, 331:489-495, 1994.
Taber's Cyclopedic Medical Dictionary, 18th Ed., p. 747, Feb. 1997.
U.S. Appl. No. 07/989,611, May 12, 1993, Office Action.
U.S. Appl. No. 07/989,611, Aug. 1, 1994, Office Action.
U.S. Appl. No. 07/989,611, Nov. 3, 1994, Notice of Allowance.
U.S. Appl. No. 08/148,809, Sep. 16, 1994, Office Action.
U.S. Appl. No. 08/148,809, May 30, 1995, Office Action.
U.S. Appl. No. 08/148,809, Dec. 15, 1995, Notice of Allowance.
U.S. Appl. No. 08/252,124, Jun. 5, 1995, Office Action.
U.S. Appl. No. 08/252,124, Jan. 5, 1996, Office Action.
U.S. Appl. No. 08/252,124, May 22, 1996, Notice of Allowance.
U.S. Appl. No. 08/259,410, Feb. 2, 1995, Office Action.
U.S. Appl. No. 08/259,410, Jun. 1, 1995, Office Action.
U.S. Appl. No. 08/259,410, Feb. 6, 1998, Notice of Allowance.
U.S. Appl. No. 08/638,076, Jan. 21, 1997, Office Action.
U.S. Appl. No. 08/638,076, Oct. 17, 1997, Notice of Allowance.
U.S. Appl. No. 08/824,031, Mar. 16, 1998, Office Action.
U.S. Appl. No. 08/824,031, Sep. 14, 1998, Office Action.
U.S. Appl. No. 08/824,031, Apr. 13, 1999, Office Action.
U.S. Appl. No. 08/824,031, Jul. 15, 1999, Notice of Allowance.
U.S. Appl. No. 08/883,246, Jul. 23, 1998, Office Action.
U.S. Appl. No. 08/883,246, Apr. 12, 1999, Office Action.
U.S. Appl. No. 08/883,246, Oct. 13, 1999, Office Action.
U.S. Appl. No. 08/883,246, Oct. 23, 2000, Office Action.
U.S. Appl. No. 08/883,246, Jul. 11, 2001, Office Action.
U.S. Appl. No. 08/883,246, Sep. 11, 2001, Notice of Allowance.
U.S. Appl. No. 09/057,108, Jul. 10, 2000, Office Action.
U.S. Appl. No. 09/057,108, Oct. 25, 2000, Notice of Allowance.
U.S. Appl. No. 09/262,402, Mar. 29, 2000, Office Action.
U.S. Appl. No. 09/262,402, May 30, 2000, Notice of Allowance.
U.S. Appl. No. 09/395,901, Jun. 27, 2000, Office Action.
U.S. Appl. No. 09/395,901, Nov. 6, 2000, Office Action.
U.S. Appl. No. 09/395,901, Apr. 20, 2001, Notice of Allowance.
U.S. Appl. No. 09/395,901, Sep. 10, 2001, Notice of Allowance.
U.S. Appl. No. 09/610,099, Jul. 11, 2002, Office Action.
U.S. Appl. No. 09/610,099, Dec. 24, 2002, Notice of Allowance.
U.S. Appl. No. 09/651,344, Feb. 28, 2003, Office Action.
U.S. Appl. No. 09/651,344, Nov. 7, 2003, Office Action.
U.S. Appl. No. 09/651,344, Apr. 20, 2004, Notice of Allowance.
U.S. Appl. No. 09/707,746, Feb. 16, 2005, Office Action.
U.S. Appl. No. 09/707,746, Jul. 7, 2005, Office Action.
U.S. Appl. No. 09/707,746, Nov. 15, 2005, Notice of Allowance.
U.S. Appl. No. 09/769,109, Oct. 23, 2001, Office Action.
U.S. Appl. No. 09/769,109, Jun. 17, 2002, Office Action.
U.S. Appl. No. 09/769,109, Sep. 9, 2002, Notice of Allowance.
U.S. Appl. No. 09/988,541, Mar. 17, 2004, Office Action.
U.S. Appl. No. 09/988,541, Feb. 28, 2005, Office Action.
U.S. Appl. No. 09/988,541, May 25, 2005, Office Action.
U.S. Appl. No. 09/988,541, Aug. 24, 2005, Office Action.
U.S. Appl. No. 09/988,541, Nov. 8, 2005, Office Action.
U.S. Appl. No. 09/988,541, Dec. 13, 2005, Notice of Allowance.
U.S. Appl. No. 10/033,689, Sep. 30, 2003, Office Action.
U.S. Appl. No. 10/152,272, Jan. 24, 2005, Office Action.
U.S. Appl. No. 10/152,272, May 13, 2005, Notice of Allowance.
U.S. Appl. No. 10/335,065, Mar. 17, 2005, Office Action.
U.S. Appl. No. 10/335,065, Jun. 10, 2005, Office Action.
U.S. Appl. No. 10/335,065, Nov. 17, 2005, Notice of Allowance.
U.S. Appl. No. 10/335,147, Dec. 13, 2005, Office Action.
U.S. Appl. No. 10/335,147, Apr. 17, 2006, Office Action.
U.S. Appl. No. 10/335,147, Oct. 4, 2006, Notice of Allowance.
U.S. Appl. No. 10/357,984, Jan. 9, 2006, Office Action.
U.S. Appl. No. 10/357,984, Mar. 16, 2006, Office Action.
U.S. Appl. No. 10/357,984, Sep. 28, 2006, Office Action.
U.S. Appl. No. 10/357,984, Mar. 23, 2007, Office Action.
U.S. Appl. No. 10/357,984, Nov. 14, 2007, Office Action.
U.S. Appl. No. 10/652,182, Aug. 9, 2006, Office Action.
U.S. Appl. No. 10/652,182, Feb. 22, 2007, Notice of Allowance.
U.S. Appl. No. 10/660,288, Nov. 15, 2005, Office Action.
U.S. Appl. No. 10/660,288, Mar. 9, 2006, Office Action.
U.S. Appl. No. 10/660,288, Aug. 24, 2006, Office Action.
U.S. Appl. No. 10/660,288, Feb. 1, 2007, Office Action.
U.S. Appl. No. 10/660,288, Jun. 28, 2007, Office Action.
U.S. Appl. No. 10/660,288, Apr. 29, 2009, Office Action.
U.S. Appl. No. 10/660,288, Aug. 3, 2009, Office Action.
U.S. Appl. No. 10/660,288, Mar. 30, 2010, Office Action.
U.S. Appl. No. 10/660,288, Mar. 29, 2011, Office Action.
U.S. Appl. No. 10/660,288, Sep. 30, 2011, Notice of Allowance.
U.S. Appl. No. 10/729,541, Dec. 12, 2006, Office Action.
U.S. Appl. No. 10/729,541, Jun. 18, 2007, Office Action.
U.S. Appl. No. 10/729,541, Jan. 8, 2008, Office Action.
U.S. Appl. No. 10/729,541, Sep. 23, 2008, Office Action.
U.S. Appl. No. 10/729,541, May 1, 2009, Office Action.
U.S. Appl. No. 10/729,541, Nov. 16, 2009, Notice of Allowance.
U.S. Appl. No. 10/729,541, Mar. 25, 2010, Notice of Allowance.
U.S. Appl. No. 10/729,541, Jul. 12, 2010, Notice of Allowance.
U.S. Appl. No. 10/737,668, Nov. 2, 2005, Office Action.
U.S. Appl. No. 10/737,668, Feb. 16, 2006, Office Action.
U.S. Appl. No. 10/737,668, Oct. 19, 2006, Office Action.
U.S. Appl. No. 10/737,668, Jun. 7, 2007, Office Action.
U.S. Appl. No. 10/737,668, Nov. 28, 2007, Office Action.
U.S. Appl. No. 10/737,668, Jun. 26, 2008, Notice of Allowance.
U.S. Appl. No. 10/742,406, Mar. 23, 2007, Office Action.
U.S. Appl. No. 10/742,406, Sep. 10, 2007, Notice of Allowance.
U.S. Appl. No. 10/742,406, Jan. 11, 2008, Notice of Allowance.
U.S. Appl. No. 10/746,210, Apr. 5, 2007, Office Action.
U.S. Appl. No. 10/746,210, Aug. 21, 2007, Office Action.
U.S. Appl. No. 10/746,210, Jul. 9, 2008, Notice of Allowance.
U.S. Appl. No. 10/813,449, Sep. 5, 2006, Office Action.
U.S. Appl. No. 10/813,449, Jul. 16, 2007, Office Action.
U.S. Appl. No. 10/813,449, Jan. 25, 2008, Office Action.
U.S. Appl. No. 10/813,449, Aug. 14, 2008, Office Action.
U.S. Appl. No. 10/813,449, Sep. 15, 2008, Office Action.
U.S. Appl. No. 10/813,449, Feb. 3, 2009, Office Action.
U.S. Appl. No. 10/813,449, Aug. 28, 2009, Office Action.
U.S. Appl. No. 10/813,449, May 27, 2010, Office Action.
U.S. Appl. No. 10/909,531, Apr. 4, 2007, Office Action.
U.S. Appl. No. 10/909,531, Dec. 26, 2007, Office Action.
U.S. Appl. No. 10/909,531, Jun. 13, 2008, Office Action.
U.S. Appl. No. 10/909,531, Feb. 9, 2009, Office Action.
U.S. Appl. No. 10/909,531, Sep. 16, 2009, Office Action.
U.S. Appl. No. 10/909,531, Apr. 29, 2010, Notice of Allowance.
U.S. Appl. No. 10/909,531, Aug. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/948,445, Jul. 11, 2007, Office Action.
U.S. Appl. No. 11/199,338, Jan. 25, 2007, Office Action.
U.S. Appl. No. 11/199,338, Oct. 5, 2007, Office Action.
U.S. Appl. No. 11/199,338, Dec. 28, 2007, Office Action.
U.S. Appl. No. 11/199,338, Apr. 23, 2008, Office Action.
U.S. Appl. No. 11/199,338, Jan. 6, 2009, Office Action.
U.S. Appl. No. 11/199,496, Apr. 1, 2009, Office Action.
U.S. Appl. No. 11/199,496, Aug. 21, 2009, Office Action.
U.S. Appl. No. 11/199,496, Apr. 23, 2010, Office Action.
U.S. Appl. No. 11/199,496, Apr. 28, 2011, Office Action.
U.S. Appl. No. 11/199,496, Aug. 18, 2011, Notice of Allowance.
U.S. Appl. No. 11/199,515, Aug. 20, 2008, Office Action.
U.S. Appl. No. 11/199,515, Nov. 13, 2008, Office Action.
U.S. Appl. No. 11/199,515, Jun. 10, 2009, Office Action.
U.S. Appl. No. 11/199,515, Dec. 24, 2009, Notice of Allowance.
U.S. Appl. No. 11/199,515, Apr. 2, 2010, Notice of Allowance.
U.S. Appl. No. 11/199,515, Aug. 2, 2010, Notice of Allowance.
U.S. Appl. No. 11/273,107, Jun. 14, 2007, Office Action.
U.S. Appl. No. 11/273,107, Jan. 18, 2008, Office Action.
U.S. Appl. No. 11/273,107, Sep. 5, 2008, Office Action.
U.S. Appl. No. 11/273,107, Apr. 9, 2009, Office Action.
U.S. Appl. No. 11/273,107, Oct. 28, 2009, Office Action.
U.S. Appl. No. 11/273,107, Jun. 2, 2010, Office Action.
U.S. Appl. No. 11/273,107, Oct. 27, 2010, Office Action.
U.S. Appl. No. 11/273,107, Jun. 2, 2011, Notice of Allowance.
U.S. Appl. No. 11/363,005, Jun. 22, 2007, Office Action.
U.S. Appl. No. 11/363,005, Dec. 14, 2007, Office Action.
U.S. Appl. No. 11/363,005, Apr. 17, 2008, Office Action.
U.S. Appl. No. 11/363,005, Dec. 23, 2008, Office Action.
U.S. Appl. No. 11/363,005, Jul. 10, 2009, Notice of Allowance.
U.S. Appl. No. 11/363,005, Jan. 14, 2010, Notice of Allowance.
U.S. Appl. No. 11/363,005, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 11/389,762, Sep. 20, 2007, Notice of Allowance.
U.S. Appl. No. 11/389,762, Nov. 23, 2007, Notice of Allowance.
U.S. Appl. No. 11/390,937, Sep. 7, 2007, Office Action.
U.S. Appl. No. 11/391,951, Oct. 28, 2008, Office Action.
U.S. Appl. No. 11/391,951, Jan. 30, 2009, Office Action.
U.S. Appl. No. 11/391,951, Aug. 26, 2009, Office Action.
U.S. Appl. No. 11/391,951, Jun. 23, 2010, Office Action.
U.S. Appl. No. 11/465,527, Feb. 3, 2010, Office Action.
U.S. Appl. No. 11/465,527, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 11/552,593, Aug. 21, 2008, Office Action.
U.S. Appl. No. 11/552,593, Feb. 5, 2009, Office Action.
U.S. Appl. No. 11/552,593, Oct. 13, 2009, Notice of Allowance.
U.S. Appl. No. 11/552,593, Mar. 22, 2010, Notice of Allowance.
U.S. Appl. No. 11/552,593, Jul. 22, 2010, Notice of Allowance.
U.S. Appl. No. 11/688,722, Mar. 10, 2010, Office Action.
U.S. Appl. No. 11/688,722, Jul. 29, 2010, Notice of Allowance.
U.S. Appl. No. 11/891,358, Apr. 26, 2010, Office Action.
U.S. Appl. No. 11/891,358, Oct. 19, 2010, Office Action.
U.S. Appl. No. 11/891,358, Aug. 31, 2011, Office Action.
U.S. Appl. No. 11/891,358, Nov. 18, 2011, Notice of Allowance.
U.S. Appl. No. 11/891,358, Apr. 10, 2012, Notice of Allowance.
U.S. Appl. No. 11/891,513, Apr. 9, 2010, Office Action.
U.S. Appl. No. 11/891,513, Sep. 28, 2010, Office Action.
U.S. Appl. No. 11/891,513, Aug. 31, 2011, Office Action.
U.S. Appl. No. 11/891,513, Nov. 1, 2011, Notice of Allowance.
U.S. Appl. No. 11/891,513, May 8, 2012, Notice of Allowance.
U.S. Appl. No. 11/960,593, Sep. 14, 2010, Office Action.
U.S. Appl. No. 11/960,593, Nov. 3, 2010, Office Action.
U.S. Appl. No. 11/960,593, Apr. 28, 2011, Office Action.
U.S. Appl. No. 11/960,593, Jul. 1, 2013, Notice of Allowance.
U.S. Appl. No. 11/997,379, Jul. 13, 2011, Office Action.
U.S. Appl. No. 11/997,379, Feb. 28, 2012, Office Action.
U.S. Appl. No. 11/997,379, May 11, 2012, Notice of Allowance.
U.S. Appl. No. 12/182,836, Oct. 5, 2010, Office Action.
U.S. Appl. No. 12/182,836, Jun. 23, 2011, Office Action.
U.S. Appl. No. 12/182,836, May 17, 2013, Office Action.
U.S. Appl. No. 12/247,012, Oct. 13, 2011, Office Action.
U.S. Appl. No. 12/247,012, Mar. 16, 2012, Office Action.
U.S. Appl. No. 12/247,012, Aug. 13, 2012, Notice of Allowance.
U.S. Appl. No. 12/257,127, Aug. 30, 2010, Office Action.
U.S. Appl. No. 12/257,127, Dec. 22, 2010, Office Action.
U.S. Appl. No. 12/257,127, Jul. 6, 2011, Office Action.
U.S. Appl. No. 12/257,127, Jan. 12, 2012, Office Action.
U.S. Appl. No. 12/257,127, Sep. 20, 2012, Notice of Allowance.
U.S. Appl. No. 12/334,077, Oct. 27, 2010, Office Action.
U.S. Appl. No. 12/334,077, Jul. 21, 2011, Office Action.
U.S. Appl. No. 12/334,077, Jan. 16, 2013, Office Action.
U.S. Appl. No. 12/334,077, Oct. 11, 2013, Notice of Allowance.
U.S. Appl. No. 12/334,085, Dec. 23, 2010, Office Action.
U.S. Appl. No. 12/334,085, Aug. 4, 2011, Office Action.
U.S. Appl. No. 12/334,085, Jan. 9, 2012, Notice of Allowance.
U.S. Appl. No. 12/873,728, Sep. 11, 2012, Office Action.
U.S. Appl. No. 12/873,728, May 3, 2013, Office Action.
U.S. Appl. No. 12/873,728, Aug. 23, 2013, Office Action.
U.S. Appl. No. 12/873,728, Nov. 4, 2013, Notice of Allowance.
U.S. Appl. No. 12/950,338, Jun. 15, 2011, Office Action.
U.S. Appl. No. 12/950,338, Nov. 1, 2011, Notice of Allowance.
U.S. Appl. No. 12/950,338, Aug. 8, 2012, Notice of Allowance.
U.S. Appl. No. 12/955,848, Jun. 30, 2011, Office Action.
U.S. Appl. No. 12/955,848, Nov. 15, 2011, Office Action.
U.S. Appl. No. 12/955,863, Jan. 6, 2012, Office Action.
U.S. Appl. No. 12/955,863, May 15, 2012, Notice of Allowance.
U.S. Appl. No. 12/955,869, Oct. 18, 2011, Office Action.
U.S. Appl. No. 12/955,869, Mar. 22, 2012, Notice of Allowance.
U.S. Appl. No. 12/961,239, Jul. 26, 2011, Notice of Allowance.
U.S. Appl. No. 12/966,961, Aug. 18, 2011, Notice of Allowance.
U.S. Appl. No. 13/022,050, Jul. 11, 2011, Office Action.
U.S. Appl. No. 13/022,050, Apr. 26, 2012, Office Action.
U.S. Appl. No. 13/022,050, Jul. 6, 2012, Notice of Allowance.
U.S. Appl. No. 13/333,411, Dec. 18, 2014, Office Action.
U.S. Appl. No. 13/333,411, Apr. 1, 2015, Office Action.
U.S. Appl. No. 13/333,411, Apr. 4, 2016, Office Action.
U.S. Appl. No. 13/443,659, Nov. 13, 2013, Office Action.
U.S. Appl. No. 13/443,659, Jun. 11, 2014, Notice of Allowance.
U.S. Appl. No. 13/455,053, Nov. 27, 2013, Office Action.
U.S. Appl. No. 13/455,053, Jun. 9, 2014, Notice of Allowance.
U.S. Appl. No. 13/485,388, May 21, 2015, Office Action.
U.S. Appl. No. 13/485,388, Oct. 7, 2015, Notice of Allowance.
U.S. Appl. No. 13/525,875, May 28, 2014, Office Action.
U.S. Appl. No. 13/525,875, Sep. 30, 2014, Office Action.
U.S. Appl. No. 13/525,875, Dec. 10, 2014, Notice of Allowance.
U.S. Appl. No. 13/593,154, Jan. 8, 2013, Notice of Allowance.
U.S. Appl. No. 13/615,523, Feb. 26, 2016, Office Action.
U.S. Appl. No. 13/615,523, Aug. 18, 2016, Office Action.
U.S. Appl. No. 13/615,523, Nov. 30, 2016, Notice of Allowance.
U.S. Appl. No. 13/615,530, Jan. 17, 2013, Office Action.
U.S. Appl. No. 13/615,530, Jun. 12, 2013, Notice of Allowance.
U.S. Appl. No. 13/752,095, Oct. 17, 2014, Office Action.
U.S. Appl. No. 13/752,095, Feb. 20, 2015, Office Action.
U.S. Appl. No. 13/752,095, Jun. 12, 2015, Notice of Allowance.
U.S. Appl. No. 13/791,858, Nov. 10, 2015, Office Action.
U.S. Appl. No. 13/791,858, Mar. 15, 2016, Notice of Allowance.
U.S. Appl. No. 13/870,628, Jul. 13, 2015, Office Action.
U.S. Appl. No. 13/870,628, Nov. 12, 2015, Notice of Allowance.
U.S. Appl. No. 14/094,352, Dec. 15, 2014, Office Action.
U.S. Appl. No. 14/094,352, Jul. 8, 2015, Office Action.
U.S. Appl. No. 14/094,352, Mar. 22, 2016, Notice of Allowance.
U.S. Appl. No. 14/195,308, Dec. 18, 2014, Office Action.
U.S. Appl. No. 14/195,308, Aug. 11, 2015, Office Action.
U.S. Appl. No. 14/195,308, Dec. 4, 2015, Notice of Allowance.
U.S. Appl. No. 14/511,730, Jan. 20, 2017, Office Action.
U.S. Appl. No. 14/674,756, Mar. 17, 2017, Office Action.
U.S. Appl. No. 90/006,469, Nov. 29, 2002, Request for Continued Examination.
U.S. Appl. No. 90/006,469, Sep. 10, 2004, Office Action.
U.S. Appl. No. 90/006,469, Sep. 27, 2005, Notice of Re-Issue.
U.S. Appl. No. 90/006,469, Jun. 27, 2006, Request for Continued Examination.
Related Publications (1)
Number Date Country
20180228478 A1 Aug 2018 US